Clemson University

TigerPrints
All Dissertations

Dissertations

5-2020

Nano-Scintillators as Next Generation Tools for Optogenetics
Ashley Dickey
Clemson University, dickey@g.clemson.edu

Follow this and additional works at: https://tigerprints.clemson.edu/all_dissertations
Part of the Chemistry Commons

Recommended Citation
Dickey, Ashley, "Nano-Scintillators as Next Generation Tools for Optogenetics" (2020). All Dissertations.
2966.
https://tigerprints.clemson.edu/all_dissertations/2966

This Dissertation is brought to you for free and open access by the Dissertations at TigerPrints. It has been
accepted for inclusion in All Dissertations by an authorized administrator of TigerPrints. For more information,
please contact kokeefe@clemson.edu.

NANO-SCINTILLATORS AS NEXT GENERATION TOOLS
FOR OPTOGENETICS
A Dissertation
Presented to
the Graduate School of
Clemson University
In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
Chemistry
by
Ashley Dickey
May 2020
Accepted by:
Dr. Joseph Kolis, Committee Chair
Dr. William Pennington
Dr. Julia Brumaghim
Dr. Stephen Creager

ABSTRACT

Optogenetics is a technique that is used to study neural pathways and has the
ability to activate or silence synaptic behavior using visible light. Currently, the visible
light sources used for optogenetics are surgically implanted into the brain tissue, but this
harmful and invasive technique may be avoided if suitable scintillating nanoparticles can
be inserted via injection. The proposed nano-scintillator particles must adhere to rigorous
parameters including being under 100 nm, uniform, nontoxic, and dispersible to be
successful in this biological system. The phase, crystallinity, and dopant concentration
must be optimized to absorb X-ray radiation and emit photons of the desired energy
necessary to activate the selected neurons. This work has led to the production of a number
of rare-earth-containing species that are attractive candidates for such an application.
A modified core-shell synthesis was developed for the production of rare earth
orthosilicate (RE2SiO5) nanoparticles. Starting with a silica core allowed for the formation
of spherical, uniform particulates. An inorganic shell capable of producing visible light
upon radiation was then deposited onto the silica. Manipulations of the shell reaction
chemistry and thermal profiles were conducted to find the conditions that produce the
desired crystallinity, phase purity, and crystallite size of the inorganic shell while limiting
the amount of particle deformation. Yttrium orthosilicate (Y2SiO5) formed as sub 100 nm
spheres, proved to be an efficient host for cerium dopants, and produced bright blue
emission under UV and X-ray excitation.
In order to continue to try to increase radioluminescence heavier rare earth
silicates, such as gadolinium orthosilicate, were targeted and are discussed in chapter 3.
This exploration produced several phases including Ce:Gd4.67(SiO4)3O (Ce:GSAP),
Ce:Gd2SiO5 (Ce:GSO), and Ce:Gd2Si2O7, (Ce:GPS) nano-scintillators. In the modified
core-shell synthesis the silica core served as both a template to ensure uniformity in size
and shape, and could be manipulated to elicit different silicate phases. The addition of
lutetium into the gadolinium silicate nanoparticles was also investigated. The mixed
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gadolinium/lutetium materials were also engineered to produce different silicate phases
and showed enhanced light output under X-ray stimulation.
Next, europium-doped rare earth oxide (Eu:RE2O3, RE = Y, Gd, Lu)
nanospheres were targeted as light sources for inhibitory opsins, such as the red-shifted
cruxhalorhodopsin. Monodispersed, spherical RE2O3 nanoparticles were produced via an
urea-assisted homogenous precipitation followed by annealing. Eu:Y2O3, Eu:Gd2O3, and
Eu:Lu2O3 were produced as uniform, 90 nm spheres and exhibited bright emission under
X-ray excitation. The effects of different annealing conditions on the particle morphology
and radioluminescence intensity were investigated. Additionally, two luminescenceenhancing techniques applied to the Eu:Y2O3 nanoparticles were shown to significantly
increase the radioluminescence of the nanoparticles.
Multiple synthetic routes for the synthesis of terbium-doped yttrium oxysulfide
(Tb:Y2O2S) nanoparticles, that would meet the constraints for noninvasive optogenetic
studies, were compared. Of the three methods used to synthesize the Y2O2S phase, the coprecipitation synthesis produced particles that meet the requirements of uniformity,
dispersity, and sub 100 nm size to be tested for noninvasive optogenetics. Luminescence
measurements of the Tb:Y2O2S nanoparticles under both UV and X-ray excitation were
collected. The nano-scintillators exhibited the desired bright green emission with an
integrated intensity greater than that of a commercial cerium doped lutetium orthosilicate
(Ce:LSO) standard. The Tb:Y2O2S nanoparticles presented herein offer the unique
potential to activate green light absorbing opsins without surgical implantation.
In addition, cell proliferation assays were run on human cells incubated with
the various nanoparticles as a preliminary cytotoxicity assessment. Cells exposed to the
tested nanoparticles did not show a statistically significant difference in viability compared
to control cells. Furthermore, promising results on surface modification, toxicity,
biodistribution, and immune response studies carried out on the Ce:YSO nanoparticles are
also discussed. The ability to produce these particles in a straightforward, uniform, and
dispersible manner as well as their relative chemical and biological inertness make them
exciting candidates for the optogenetics toolbelt.
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CHAPTER ONE
INTRODUCTION
1.1 Optogenetics
1.1.1

Background
Optogenetics is a method that combines optics and genetics to monitor and control

living tissue. This cutting edge technique targets genetically encoded molecules to specific
neurons in the brain and enables their activity to be driven or silenced by light. It is an
emerging field, with its breakthrough in 2005 when Karl Deissoroth’s lab published the
first demonstration of a single-component optogenetic system in cultured mammalian
neurons.1 Transmembrane proteins called opsins are genetically engineered into
mammalian neurons to provide millisecond-scale temporal precision which allows
researchers to examine the causal role of specific action potential patterns in specified
neurons. The use of opsins provides numerous advantageous over previous methods such
as 1) one-component simplicity of integration 2) minimal interference with endogenous
function 3) reliability of use in numerous in vitro and in vivo experiments 4) cell type
specificity 5) range of action – excitation and inhibition 6) low light requirements.2 This
new field has the ability to provide formerly unattainable information about neural
pathways and signaling. Furthermore, not only does optogenetics allow for the monitoring
of neural activity it also provides a means to control it, even in freely moving animals.3
There are six general steps to traditional optogenetic studies (Figure 1.1).4 The first
step involves piecing together a genetic construct consisting of a gene encoding opsin and
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a promoter. An opsin is a light sensitive transmembrane protein and a promoter is a region
of DNA that initiates transcription. The next step is to insert the construct into a virus. The
virus can then be injected into the brain in order to deliver the genetic construct and produce
expression of the light sensitive opsins in targeted neurons. Step four deals with providing
a light source to activate the opsins. Conventionally, fiber optics or LEDs are implanted
into the brain tissue to provide light of a specific wavelength, causing the opsins to open
and allowing for an influx of ions across the neural membrane. Lastly, the synaptic
behavior caused by the influx of ions can be recorded using electrophysiology techniques
such as voltage or current clamp.

2

Figure 1.1 Schematic of the six traditional steps to optogenetics. Reproduced from Buchen,
L. Neuroscience: Illuminating the Brain. Nat. News 2010, 465 (7294), 26–28. Copyright
2010 with permission from Springer Nature.
1.1.2 Opsins
Opsins are light sensitive proteins and a key component to optogenetic technology.
There are two main classes of opsins, Type I opsins (microbial) are found in Archaea,
Bacteria, and Eukaryota. Whereas, Type II opsins (animal) are found in mammalian retina.
Both Type I and Type II opsins are members of the 7-Transmembrane (7-TM) rhodopsins
3

family and therefore their photo-sensing is dependent upon a covalent interaction between
a conserved lysine residue in the 7-transmembrane (7-TM) helix and a retinal
chromophore.2 The retinal molecule forms a covalent bond to the binding pocket of the 7TM helices forming a protonated retinal Schiff base (RSBH+). Type I opsins serve as direct
ion channels or pumps, whereas Type II opsins initiate a secondary protein called Gprotein. In Type I opsins retinal isomerizes from the all-trans to the 13-cis inducing a
conformational change in the protein which shifts the dipole of the RSBH+ that eventually
leads to cation permeation across the membrane (Figure 1.2).7 For Type II opsins the
retinal molecule goes from the 11-cis to the all trans conformation and this conformational
change induces activation of the phototransduction cascade. Due to their faster kinetics,
Type I opsins are used for neural control during optogenetics studies.

Figure 1.2 Retinal isomerization.

4

There are three main branches of Type I opsins that have found purchase in
optogenetic studies: bacteriorhodopsins, halorhodopsins, and channelrhodopsins (Figure
1.3).8 Bacteriorhodopsin was the first member of this family discovered and is capable of
pumping protons out of the cell into the extracellular space.9 Halorhodopsins are activated
by green light and pump chloride ions into the neuron.10 Both bacteriorhodopsins and
halorhodopsins actions are hyperpolarizing and therefore inhibitory. Alternatively,
channelrhodopsins serve as nonspecific cation channels (H+ > Na+ > K+ > Ca2+) causing
depolarization and excitation. The first identified types of channelrhodopsin, ChR1 and
ChR2 were found in a green algae named Chlamydomonas reinhardtii. ChR2 was the first
opsin used to excite neurons and is now the prototypical and most widely used optogenetic
tool.1 ChR2 absorbs blue light with an absorbance maximum of 480nm. The absorbance of
blue light induces a conformational change within the opsin producing a pore 6 Å in
diameter.

Figure 1.3 Type 1 (microbial) rhodopsins.
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Many more variants of channelrhodopsins have been discovered or engineered to
augment kinetics, desensitization, spectral response, light sensitivity, channel conductance,
ion selectivity, and membrane trafficking and expression.7 One disadvantage of ChR2 is
the production of spurious action potential peaks due to slow channel off kinetics. In
response to this issue a channelrhodopsin variant called ChETA was engineered to have
much faster recovery and in doing so it reduces extra spikes and increases the precision of
optogenetic experiments.11 Scientists have even been able to manipulate the cation
conducting channelrhodopsin into to a chloride ion channel which exhibits a 200 fold
increase in light sensitivity to a pump based inhibitory opsin such as the halorhodopsins.
This switch in function was achieved by incorporating directed single site mutations to
reverse the polarity surrounding the pore.12 Another engineered channelrhodopsin variant
(CatCh) is ~70 fold more light sensitive than wildtype ChR2.13 The CatCh variant
possesses Ca2+ permeability which raises the internal surface potential, enabling activation
of voltage-gated Na+ channels and indirectly increasing light sensitivity. There has been
multiple red shifted opsins (VChR1, C1V1, ReaChR) designed due to the reduced
scattering and absorption of longer wavelength light within biological systems.14–16 Very
fast Chrimson (vf-Chrimson) is a newly developed opsin that is both red shifted and
displays fast closing kinetics.17 Research efforts continue to generate new opsin variants in
effort to increase the precision and feasibility of optogenetics.
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1.1.3 Light Sources
The most common way to conduct optogenetic experiments is with the use of a
single fiber to couple light to the brain region of interest. Although this method provides
sufficient light intensity it is restrictive in its temporal resolution. Many advances have
been made to help alleviate this issue including the use of fiber bundles, waveguide
devices, and millimeter size LEDs within glass pipettes. Still, these traditional light sources
are wired and therefore obstructive to studies involving freely moving animals. Micro
LEDs have been fabricated for injectable, wireless optogenetics to combat this problem.
For example, Montgomery et al. reported on a fully internal implant device capable of
exciting opsins within the brain, spine, and in peripheral nerves of mice models with
minimal interference of the animal behavior. The complete device, consisting of a power
receiving coil, circuit, and LED was reported to be 10–25 mm3 in size and only weighting
20–50 mg depending on the target application.18 Although, the micro LEDs offer increased
mobility they still require surgical implantation. Surgical implantation of light sources has
the potential to cause serious and irreparable brain tissue damage and therefore
optogenetics is turning towards noninvasive alternatives. Recently, researchers have
started investigating infrared (IR) radiation because it is capable of penetrating further into
biological systems than visible light, however currently available opsins do not absorb IR
wavelengths.19,20 Upconverting nanoparticles can be used to absorb IR radiation and
convert it to visible light to activate the opsins. Elegant studies have recently been reported
using NaYF4 nanoparticles to convert IR radiation into visible light wavelengths necessary
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for optogenetics studies. Chen et al. were able to alter the behavior of awake moving mice
with upconverting nanoparticles injected to the granule cells of the hippocampus.21
Although this an impressive result, there are still depths of interest that cannot be reached
by IR radiation. In order to meet new technological demands, X-rays in conjunction with
nano-scintillators, that are able to absorb the high energy radiation and convert it to visible
light, are proposed in this dissertation to further the penetration depth of optogenetic
studies.
1.1.4 Applications
Optogenetic studies have already provided innumerable insights into the brain
including information on the neural mechanisms underlying memories,22 emotions,23 and
various mental health disorders.24 This newly gathered information has led to the
confirmation of theories, detection of information processing locations, as well as the
identification of new potential therapeutic targets and treatments. Examples of some
successes of optogenetic research in these various areas are discussed below.
Optogenetic studies have led to the confirmation of long accepted, but not verified
theories such as the roles of different brain structures in mental health disorders. For
example, it has been theorized, but recently confirmed with data collected using
optogenetics that corticostriatal circuits play an important role in obsessive compulsive
disorder (OCD).25 Additionally, optogenetics enabled studies have located multiple brain
regions where complex microcircuits modulate anxiety-like behaviors.26 Similarly, several
studies have led to the conclusion that neurons in the amygdala and cortex play a pivotal
role in fear learning.27 This new information could provide important implications into
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treatments for disorders associated with anxiety and fear such as post-traumatic stress
disorder (PTSD).28 Optogenetics has also identified potential target areas, specifically the
prefrontal cortex and the globus-pallidus subthalamic nuclei systems, within the brain to
stimulate as a treatment for schizophrenia. Although, this treatment is far from being used
in humans the information gained could lead to optogenetically inspired deep brain
stimulation.29
Not only has optogenetics provided new information to help understand neural
circuitry, but it has also been successful for in vivo treatment of multifarious disorders. For
example, optogenetic stimulation of dentate gyrus engrams improved memory
performance in Alzheimer’s animal models.30 Additionally, models have also shown
improved recovery of sensorimotor function when optogenetic therapy is applied to stroke
induced mice.31 Optogenetic results have helped progress towards the first clinical trials of
stem cell derived mesencephalic dopaminergic (mesDA) neurons for treatment of
Parkinson’s disease by resolving mechanistic questions involving graft function and graftto-host connectivity.32 Remarkably, scientists have been able to reverse cocaine-evoked
synaptic plasticity and abolished behavioral sensitization to cocaine in mice.33
Although, optogenetics was initially envisioned as a tool for the precision targeting
and study of specific neural circuits it has steadily moved out of the brain and proved useful
in a number of different systems including cardiac control,34 pain management,35 vision
restoration,36 as well as in the management of a variety of biochemical events.32
Optogenetics was readily extended to the peripheral nervous system in effort to gain
understanding on how it interacts with sensory neurons and their involvement in pain.
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Current pain relief techniques include direct electrical and pharmacological
neuromodulation both aimed at sensory afferent neurotransmission. However, neither of
these techniques offer much temporal or spatial control leaving room for an improved
neuromodulation approach to pain relief. The capability to control targeted peripheral
axons would facilitate novel experiments to examine the processes mediated by these axons
and could have therapeutic potential. In fact, optogenetic treatment has already succeeded
in inhibiting inflammatory and neuropathic pain in freely moving animals.35
In 2010 optogenetic control of cardiac muscle by opsin expression in
cardiomyocytes was published and discoveries in the area have continued to rapidly
expand.37 Since the introduction of optogenetics into cardiac research, scientists have been
able to produce simulated tachycardia, bradycardia, atrioventricular blocks, and cardiac
arrest under light illumination of nonmammalian vertebrates.38 Additionally, cardiac
optogenetics has been used to study epigenetic heart formation and blood vessel
development enabling scientists to find potential treatments of cardiac rhythm disorders.
Optogenetic researchers have also set their sights on vision restoration. Inherited
retinal disease (IRD) is the most common cause of blindness in developed countries and
patients exhibit photoreceptor cell loss in early stages of the disease. Current treatments for
IRD such as electronic retinal implants are limited in their resolution and field of vision.
Expression of engineered opsins in remaining retinal neurons could allow for increased
spatial resolution and acuity. Preclinical animal trial results have been promising for the
safety and feasibility of optogenetic approaches to vision restoration. For example, Chaffiol
et al. demonstrated activation of retinal ganglion cells (RGC) in macaques using Ca2+-

10

permeable channelrhodopsin (CatCh).39 Due to the favorable results of this study and
many others, clinical testing of optogenetic treatment for IRD is currently being
conducted.40
Optogenetics has also found purchase in control of skeletal muscles,41 gene
expression,42 gut motility,43 and insulin regulation.44 For example, one application reported
for implantation of opsins into skeletal muscle is the potential to restore mobility of vocal
cords in patients suffering from laryngeal paralysis. A promising result in this area came
from Bruegmann et al. when they were able to selectively open and close the vocal cords
of mice through optogenetic stimulation of small intralaryngeal muscles.41 Another
emerging application of optogenetics is the control of gene expression in effort to sort out
the intricate molecular mechanisms of complex biological systems. It is complementary to
other genetic engineering systems with enhanced spatiotemporal resolution. In 2018 gut
motility researchers published the first demonstration of evoking contractions throughout
the entire colon by optogenetic control of the enteric nervous system.43 In vitro and in vivo
studies conducted by Kushibiki et al. demonstrated the induction of insulin secretion in
optogenetically engineered β cells lines and impressively ameliorated hypoglycemia in a
diabetic mouse models.44 This is an exciting option for diabetic therapy which would
reduce the high cost of insulin injections for a disease that affects hundreds of millions of
people worldwide. The above is by no means an exhaustive list of optogenetic
breakthroughs, but a selected sample to show that the possibilities of optogenetic research
appear limitless.
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1.2 Scintillation
1.2.1 Mechanism
Scintillation is defined as the luminescence induced by ionizing radiation in
transparent dielectric media. Scintillators are used in several diverse detection systems such
as medical imaging (PET and CT scanner), homeland security, high energy physics
calorimetry, and oil drilling exploration.45,46 Scintillators have been produced in many
forms including ceramics, glasses, organic crystals and liquids, plastics, gases, and the most
widely used form, single crystals. The decidedly successful scintillators possess high
density, radiation hardness, low cost, and high light yield.47 However, the scintillation
process is complex and involves multiple energy conversion processes which makes it
difficult to predict ideal scintillating materials. Due to the focus of this dissertation,
discussion on the scintillation mechanism is restricted to inorganic scintillators.

Figure 1.4 Schematic of scintillation mechanism.
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There are two reported classes of

the scintillation mechanism for inorganic

materials, namely: activated scintillators which incorporate dopants to promote
scintillation or self-activated scintillators that contain intrinsic radiating centers in the form
of ions, anionic complexes, or excitation states from the matrix itself. The scintillation
mechanism can be broken into three broad stages: energy conversion, transfer to
luminescent centers, and light emission (Figure 1.4). The first stage involves the creation
of primary excitations through the interaction of high energy radiation with the material.
There are three general ways that photons will interact with electrons when traveling
through matter: the photoelectric effect, Compton scattering, and pair production. The
photoelectric effect is the transfer of energy from light radiation to electrons or other free
carriers. If the energy of the photon is greater than that of the electron binding energy the
electron will be ejected. Compton scattering is a type of inelastic scattering in which a
photon losses energy when scattered by a charge carrier. Both the photoelectric effect and
Compton scattering are dominant at low and medium energy. Pair production is the
creation of an electron and positron from a photon of sufficient energy - at least the total
rest mass energy of the two particles. Energy is progressively distributed to secondary
particles of lower energy forming an electromagnetic shower also generating inner shell
holes and hot electrons in the conduction band. Once the energy of the electrons becomes
less than the ionization threshold thermalization of electrons and holes occurs to bottom of
the conduction band and top of the valence band respectively.47
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The second stage of transfer is when the excitations travel through the crystalline
lattice. In this stage electrons and holes may be captured by different traps or defects and
decay non-radiatively. The presence of defects such as vacancies, interstitials, and
impurities diminish scintillation output and therefore have a direct effect on the scintillation
performance of the material.
Finally, luminescence from the emitting centers can occur due to excitation from
correlated electron-hole pairs, excitons, separated electron and holes through sequential
capture, or other energy transfers. Decay of an excited electron to the ground state emits
energy as visible light. The specific emission mechanism depends on both the luminescent
center and crystal lattice.
Scintillation

efficiency

is

usually

described

with

the

formula:

LY = ( 106 / β Eg ) S Q where LY is the scintillator light yield in photons per MeV, Eg is
the crystal band gap in eV, S is the transfer efficiency, Q is the quantum efficiency of the
emission center, β = Eeh/Eg, and Eeh is the energy for the creation of one electron-hole pair.
However, some processes involved in scintillation such as thermalization are not directly
included in this formula.47 There are limiting factors at each step of the energy conversion
processes of scintillation. For example, Eg, the band gap energy, is a limiting factor in the
creation of excitations. Generally, the larger the band gap the lower the number of electron
hole pairs. Transfer to luminescent centers can be limited by the charge carriers capture
probability, specific killer ions, self-trapping, defects, and interaction of excitations. For
instance, local density-induced quenching occurs from interactions between closely spaced
excitations. A number of quenching mechanisms can limit the final stage of luminescence
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as well such as electron-phonon coupling, photo-ionization, charge transfer quenching,
concentration quenching, as well as reabsorption. Today’s research is aimed at generating
a wide-ranging quantitative model used to help predict the behavior and limitation of
scintillation in various materials to target production.
1.2.2 Materials

Figure 1.5 History of the discovery of significant inorganic scintillators.
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Scintillator discovery is commonly described in four phases. The history of
prominent scintillator discoveries is illustrated in Figure 1.5.46 The first phase of earliest
scintillators includes CaWO4, uranyl salts (used by Becquerel), and ZnS (used by Crookes
and Rutherford). During the second phase, a group of alkali halide crystalline materials,
predominantly NaI:Tl and CsI:Tl were discovered. In Addition, dopants such as Tl+, Eu2+,
and Ce3+ were found to be efficient activators. Bismuth germanate (BGO) was also revealed
as a self-activated scintillator during this phase and was implemented into medical
devices.48 A cross luminescence scintillator BaF2 was likewise identified during this time.
The third phase arose from the need for precision calorimetry in high-energy physics and
for high-light-output scintillators for medical imaging. Lutetium orthosilicate (LSO) and
gadolinium oxysulfide (GOS) are standout discoveries from the third phase as they have
been implemented into a variety of medical imaging devices. Pr3+ was also found to provide
the fastest scintillation of an activated scintillator. Notably, PbWO4 and CeF3 were also
discovered during this time. PbWO4 has made an impact from its use in an electromagnetic
calorimeter allowing for the discovery of a new boson.47
Many new inorganic materials were discovered recently, however most of them
have not transferred to industrial applications. Even though it is hygroscopic, due to cost
NaI:Tl is still one of the most widely used inorganic scintillators today. However, cerium
doped rare earth silicates, particularly gadolinium orthosilicate (GSO), lutetium
orthosilicate (LSO), and mixed yttrium/lutetium orthosilicates (YLSO) have replaced BGO
for many medical applications due to their high density, fastness, and high light output.
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The final and current phase is focused more on the engineering of scintillators rather
than discovery. For example, combining different cations to control deposition of activator
energy levels in the band gap of inorganic materials to increase light yield which has led
to the production of bright garnet type scintillations.49 Present research is also focused on
the engineering of new scintillator materials such as thin films, ceramics, and nanoparticles.
Even after 60 years of product perfection, the energy resolution of NaI:Tl is about 7 % at
industrial specification. Therefore, research into increasing desired scintillation parameters
is still unsettled and currently a hot issue.
1.2.3 Radioluminescent Particles for Biomedical Applications
X-ray luminescence has emerged as an exciting option for medical diagnosis and
photodynamic therapy (PDT) due to its depth penetration and low autofluorescence in
mammalian tissues. A key factor for attaining successful X-ray luminescence technologies
is the development of efficient X-ray-excitable luminescent nanoprobes. Traditionally,
most optical probes are activated through UV or visible light absorption. More recently
upconverting nanoparticles capable of converting infrared (IR) radiation to visible light
have been implemented into bioimaging. IR radiation exhibits less scattering and
absorption in biological systems than visible light which can enable deeper tissue imaging.
However, X-ray penetration would permit unmatched penetration which is particularly
beneficial for in vivo studies and applications. Due to this, advances are being made toward
nanoparticles that can absorb X-ray radiation and convert it to visible light for the
enhancement of various biomedical imaging and therapies.
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For example, Cr:ZnGa2O4 particles were synthesized as X-ray active persistent
luminescence nanoparticles (XPLNP) to be used as optical probes for in vivo bioimaging
without the need for continuous in situ external activation. PLNPs such as LiGa5O8:Cr3+
provide high signal-to-noise and therefore are promising optical probes, however they are
excited by UV wavelengths and cannot be activated through deep tissue. Whereas, the
Cr:ZnGa2O4 particles synthesized by Xue et al. were able to be excited with low energy
X-ray in vivo up to 20 mm depths.50 Scintillating particles have also been explored for use
in multimodal imaging such as the PEG-NaGd(WO4)2:Eu nanorods capable of improving
magnetic resonance imaging (MRI), computed tomography (CT) imaging, and X-ray
imaging developed by Guo et al.51 In addition, to the unique energy transfer sensitized
radioluminescence of NaGd(WO4)2:Eu, the incorporation of Gd atoms also served as a T1
contrast agent for MRI and the X-ray attenuation ability of W atoms enabled contrast for
enhanced CT imaging.
Not only have scintillating particles enhanced imaging, but they have also been
employed as therapeutics for drug delivery and photodynamic therapy (PDT).
Nanocapsules with Gd2O2S-based shells were synthesized by Chen et al. to deliver and
monitor the release of doxorubicin (DOX), a chemotherapy drug. The presence of DOX
inside the nanocapsules inhibits the radioluminescence intensity of the Gd2O2S, therefore
its release can be monitored by tracking the ratio of radioluminescence emission peaks.
Different scintillators including LaF3:Tb, SrAl2O4:Eu2+, and Tb2O3 have been assessed for
PDT treatment. PDT uses photosensitizers which upon absorption of visible light create
cytotoxic reactive oxygen species (ROS) in cancer cells to generate apoptosis.
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Impressively, the SrAl2O4:Eu particles presented by Chen et al. induced a 35.1 % drop in
cancer cell viability when exposed to X-ray under a 4.5 cm slab of pork. It is evident that
the excellent tissue penetration of X-rays has the potential to move biomedical applications
forward.
This dissertation proposes the use of nano-scintillators as optical tools for
optogenetics. An optogenetic application asks a lot of the nanoparticles in terms of
morphology and light yield that cannot be met by the currently available nano-scintillators.
In addition to being biocompatible the nano-scintillators need to be under 100 nm,
dispersible, and produce high light yield. In order to achieve bright scintillation dense rare
earth containing silicates, oxides, and oxysulfides were targeted. It is likely due to the high
processing temperatures causing sintering of the particles that these efficient scintillating
materials have yet to be used in biomedical applications. Therefore novel synthetic and
annealing techniques were developed to achieve refractory materials as uniform and
dispersible sub-100 nm spheres.

1.3 Research Goals
The work presented in this dissertation was done with the motivation of providing
a noninvasive alternative for optogenetics by using nano-scintillators to locally convert
X-ray radiation into visible wavelengths required for opsin activation. Ideally, nanoscintillators would be injected into the bloodstream and then targeted to specific neurons,
avoiding the invasive surgical implantation of a light source. Notably, the nano-scintillators
will need surface functionalization to be targeted to the neurons. A possible route to this
involves opsins engineered to possess a commercially available SNAP-tag which would
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selectively bind to benzyl guanine functionalized nano-scintillators. Then, medical dosages
of X-rays could be applied externally to trigger the scintillation and in doing so provide
light for neural manipulation (Figure 1.6). To achieve this goal rare earth containing
nanoparticles were engineered into sub 100 nm, dispersible scintillating nanospheres. In
order to be viable candidates for optogenetic studies, the nanoparticles had to adhere to a
strict set of parameters. First, the nanoparticles need to be 100 nm or smaller in diameter
in order to pass the blood brain barrier. The shape and size of the nanoparticles also needed
to be uniform to enable reliable dosage administration. Furthermore, the nanoparticles were
optimized in their crystalline lattice, dopant, and phase in order to have the most efficient
scintillation at the nano-level possible. Finally and importantly, the nanoparticles could not
be toxic to the biological systems of interest.
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Figure 1.6 Schematic of scintillating nanoparticles for noninvasive optogenetics.

Many of the required properties for the purposed application are in opposition of
one another and therefore a niche technology of nano-scintillators was carved out to
provide a route to noninvasive optogenetics. New synthetic strategies such as the core-shell
technique used to produce dispersible rare earth silicates are described in Chapter 2.
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Chapter 3 discusses phase manipulation and host optimization to produce enhanced
scintillation in the rare earth silicates. The unique sacrificial carbon coating utilized to
increase the crystallinity and thereby increase radioluminescence intensity of rare earth
oxides is described in Chapter 4. Finally, a novel co-precipitation route to dispersible, high
light yielding oxysulfides is presented in Chapter 5.
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CHAPTER TWO
CORE-SHELL SYNTHESIS AND LUMINESCENCE OF YSO
AND LSO NANOPARTICLES
2.1 Introduction
Optogenetics is a method that combines optics and genetics to monitor and
control living tissue.1–4 This technique currently uses an invasive and potentially harmful
process to control neuronal activity by implanting LEDs into brain tissue.5 It would be
safer and potentially more versatile to improve this technique by systematically
synthesizing and characterizing nano-scintillators that could be inserted into brain tissue
via injection. These particles would serve as the visible light source to stimulate neuronal
activity. There are a number of different constraints to consider when creating such a
particle that would meet all the necessary requirements of a targeted, inoffensive means
to manipulating specific neurons in living tissue. For example, in order to access the brain
tissue the particles will have to be smaller than 100 nm. The present chapter focuses on
creating a nano-scintillator that meets the desired conditions.
A scintillator is a material that exhibits the property of luminescence, when
excited by ionizing radiation such as X-rays.6,7 The most effective scintillators possess
high density, high effective atomic number, radiation hardness, and a band gap that
enables them to absorb short wavelength, high energy radiation and reemit the energy as
photons in the visible spectrum.8 In the case of optogenetics, it would be ideal if the
scintillators are efficient enough to generate suitable visible light using energy levels
comparable to that of dental X-rays. The rare earth orthosilicates (RE2SiO5) are the initial
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family of scintillators targeted as tools for noninvasive optogenetics. The rare earth
orthosilicates were chosen because they are known to be standards in the scintillator
market.9–11 Also, the proposed optogenetics application of these particles requires an
inert, stable material, and many other known very bright scintillators are hygroscopic
halides and therefore would not be applicable in a biological system.12 Furthermore, the
rare earth orthosilicates are known to be efficient hosts for cerium doping. Cerium is an
ideal dopant because its emission, when in the orthosilicate lattice, matches the
wavelength necessary to activate channelrhodopsin, an opsin commonly employed for
optogenetic studies.13,14
This work has led to the production, through a core-shell synthetic approach,6,7 of
a number of rare earth containing silicate species that are attractive candidates for such an
application. Starting with a silica core allows for the formation of spherical, uniform
particulates. An inorganic shell capable of producing visible light under radiation can
then be deposited onto the silica. Manipulations of the shell reaction chemistry and
thermal profiles have been conducted to find the conditions that produce the desired
crystallinity, phase purity, and crystal domain size of the inorganic shell while limiting
the amount of particle deformation.
Cerium doped lutetium orthosilicate, Ce:Lu2SiO5, (Ce:LSO) was pursued first
because it is currently considered to be the brightest rare earth orthosilicate scintillator
having a reported light output of 30,000 photons/MeV.9,15 However, LSO requires
extremely high processing temperatures that were found to produce large micron
particulates by aggregation of the nanoparticles.16 In effort to produce the rare earth
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orthosilicate phase at lower temperature cerium doped yttrium orthosilicate (Ce:YSO)
was targeted. Ce:YSO materials are also bright scintillators used industrially and have
lower reported processing temperatures.17,18 The decrease in annealing temperature
allowed the Ce:YSO nanoparticles to maintain sub-100 nm sizes. Various techniques
were pursued to enhance luminescence of the Ce:YSO nanoparticles including applying
multiple yttrium containing shells, annealing in a reducing atmosphere, and introduction
of denser rare earth metals such as gadolinium and lutetium. After evaluating the best
synthetic conditions for bright radioluminescence, surface modification, toxicity,
biodistribution, and immune response studies were carried out on the Ce:YSO
nanoparticles.

2.2 Experimental
2.2.1 Materials
All materials were obtained from commercial suppliers and used without further
purification. Ethanol (EtOH 98 % water solution), anhydrous dimethylformamide (DMF),
tetraethyl orthosilicate (TEOS, 99.9 %), urea (CH4N2O,) ammonium hydroxide (NH4OH
30 % water solution), cerium nitrate (Ce(NO3)3 ·6H2O), yttrium nitrate hexahydrate
(Y(NO3)3·6H2O, 99.9 %), gadolinium nitrate (Gd(NO3)3·xH2O, 99.9 %), lutetium nitrate
(Lu(NO3)3·xH2O, 99.99 %), sodium azide (NaN3), 3-chloropropylmethoxysilane.
2.2.2 SiO2 Nanoparticle Synthesis
Silica (SiO2) nanoparticles were made using a modified Stöber process.19 The
process involves the base assisted hydrolysis and condensation of tetraethyl orthosilicate
(TEOS) in ethanol. The size of the SiO2 nanoparticles could be varied by changing the
ratios of TEOS, EtOH, H2O and NH4OH. In a typical reaction 8 mL of TEOS was
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dissolved in a solution containing 120 mL ethanol and 10 mL H2O followed by the
dropwise addition of 3 mL NH4OH 30 % soln. The reaction mixture was stirred for 48 h
at room temperature. The silica nanoparticles were collected via centrifugation and
washed several times with ethanol and water. The particles were dried overnight in an
oven at 85 °C. The obtained particles were spherical with an average diameter of 70 nm
(Figure2.1).

Figure 2.1 SEM images of SiO2 nanoparticles.
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2.2.3 Core-Shell Synthesis

Figure 2.2 Core-shell formation process of rare earth-containing silicate nanoparticles.
The rare earth silicate nanoparticles were synthesized via a 3-step, core-shell
method as depicted in Figure 2.2. First, freshly prepared 70 nm silica nanoparticles were
synthesized using a modified Stöber method20 as described above. The second step
consists of depositing the rare earth shell onto the silica core. Typically, this was
achieved by dispersing 0.12 g of the synthesized silica nanoparticles, via sonication, in a
water solution containing 0.76 g Y(NO3)3 and 0.15 mL 0.1 M Ce(NO3)3. Then, NH4OH
was added dropwise to adjust pH and enable rare earth precipitation onto the silica cores.
The solution was stirred for 24 h and the resulting particles were separated by
centrifugation, washed several times with ethanol and water, and dried at 125 °C. Next,
the amorphous core-shell particles were thermally treated in air at 900 °C for 2 h to form
the Ce:Y2O3 shell. Lastly, further annealing at higher temperatures such as 1000 °C
caused a solid state reaction between the SiO2 core and Ce:Y2O3 shell to form cerium
doped yttrium orthosilicate (Ce:Y2SiO5) nanoparticles. Cerium doped lutetium
orthosilicate (Ce:LSO), mixed lutetium/yttrium orthosilicate (LYSO), and mixed

35

gadolinium/yttrium orthosilicate (GYSO) particles were made via the same core-shell
method by varying the rare earth metal(s) and annealing temperature.
2.2.4 Azide Modification
In order to prepare the nanoparticles for subsequent organic functionalization,
azide modification of the Ce:YSO nanoparticles was sometimes conducted after the final
annealing

step

of

the

core-shell

synthesis.

First,

the

azide

linker,

3-

azidepropyltrimethoxysilane, was synthesized by nucleophilic substitution of a chloride
with an azide using 3-chloropropylmethoxysilane and sodium azide staring materials.
Typically, 684 mg NaN3 was added to a 50 mL round bottom flask followed by 3 mL
DMF. Next, the flask was covered with a rubber stopper and purged with N2 for 5 min
and heated to 90 °C in an oil bath. 1 mL 3-chloropropylmethoxysilane was injected
through the rubber stopper into the azide solution. The solution was allowed to react for
1 h. Next, in order to add the azide linker to the nanoparticles 0.5 g of the Ce:YSO
nanoparticles were dispersed in a solution of 15 mL DMF/ 1 mL H2O. 0.05 mL of freshly
prepared azide linker solution was added to the solution followed by the dropwise
addition of NH4OH. The solution was allowed to stir for 1 h. The azide functionalized
Ce:YSO nanoparticles were recovered by centrifugation and washed with ethanol and
water before being dried at 65 °C.
2.2.5 Characterization
Scanning electron microscopy (SEM) was used to study morphology and particle
size of the silica and core-shell particles. Particles to be imaged were dispersed in water
and water-bath sonicated before being deposited onto carbon tape dropwise. After drying
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at 85 °C the samples were sputter coated with platinum for 1 min. A Hitachi S4800 field
emission scanning electron microscope was used to produce images with an accelerating
voltage of 20 kV.
Examinationl of the powdered products was accomplished by using powder X-ray
diffraction to identify the core-shell reaction pathway, crystallinity, phase purity, and
crystal domain size. The PXRD measurements were obtained using a Rigaku Ultima IV
equipped with CuKα radiation (λ = 1.5406). The diffraction data were recorded over a 2 θ
range of 5 ° to 65 ° in 0.2 ° increments with a scan speed of 1 °/min. The average
crystallite sizes of the core-shell particles were calculated using the broadening of the
PXRD lines in accordance with the Scherrer equation: t = K λ/(β cos θ), where λ is the Xray wavelength, K is dimensionless shape factor, β is the broadening at half the maximum
intensity of the line sited at θ angle.
Fourier-transform infrared spectroscopy (FTIR) was used to collect infrared
spectra on the azide functionalized Ce:YSO nanoparticle powder using a Nicolet Magna
IR Spectrometer 550. The samples to be analyzed were ground with potassium bromide
(KBr) and pressed into pellets. The data was collected in the frequency range of
400-4000 cm−1 with a resolution of 4 cm−1.
For luminescence measurements 20 μg of the particles were dispersed in PDMS
films. The films were made in triplicate for each sample. Commercial Ce:LSO powder
purchased from Phosphor Technologies, with an average particle diameter of 8 μm, was
similarly prepared into films and used as a standard of comparison for emission intensity.
The photoluminescence spectra of the core-shell particles were obtained using a Jobin
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Yvon Fluorolog 3-222 spectrometer with double grating configuration and xenon lamp
source. The measurements were performed with a 3 nm slit width and scan speed of
0.1 nm/sec. The radioluminescence spectra of the core-shell particles were obtained by
irradiating the sample with a tungsten source mini X-ray tube (Amptek Inc.), operating at
a tube voltage of 50 kV and a tube current of 79 μA. The radioluminescence was
collected with a fiber bundle (Oriel) coupled to a MicroHR (Horiba Jobin Yvon)
monochromator and a cooled CCD detector (Synapse, Horiba Jobin Yvon).
2.2.6 MTS Assay
MTS assays were used as initial toxicity studies of the rare earth containing
nanoparticles towards human cell lines.21–23 The normal human dermal fibroblast
(NHDF) cells were obtained from ATCC and cultured at 37 °C in a humidified
atmosphere of 95 % air / 5 % CO2. The NHDF cells were cultured in Dulbecco’s
modified Eagle’s media (DMEM) containing 10 % FBS and 5 % L-glutamine. The cells
were plated for 72 h at 10,000 cells per well in a 96 cell well plate. The cells were
separately incubated with the silica nanoparticles (SiO2), cerium doped yttrium
orthosilicate nanoparticles (Ce:YSO), and cerium doped lutetium orthosilicate (Ce:LSO)
commercial standard powder in concentrations of 3.60×107 particles/mL, 3.60×108
particles/mL, and 3.60×109 particles/mL. After 72 h of incubation with the nanoparticles
the cells’ viability was measured using MTS assay (CellTiter 96 AQueous One Solution
Cell Proliferation Assay, Promega) following the manufacturer’s instructions.24 The
particles and media were removed from the cells and replaced with 200 μL of DMEM
media and 40 μL of the MTS tetrazolium reagent. The MTS solution was incubated with
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the cells for 3 h. The absorbance was measured using a plate reader at OD = 490 nm. The
data was collected in triplicate.

2.3 Results and Discussion
2.3.1 Lutetium Orthosilicate (LSO)
Bulk rare earth orthosilicates (RE2SiO5) are go-to materials for industrial
scintillation, currently used in numerous technologies such as security and medical
imaging, and therefore are an alluring target for optogenetics.16,25,26 Of the RE2SiO5
materials lutetium orthosilicate (LSO) is by and large reported as the brightest scintillator
owing to its increased density (7.4 g/cm3) and high X-ray stopping power.9 Bulk, single
crystal LSO is typically processed at temperatures nearing 2000 °C.27 Annealing
nanoparticles at such high temperatures causes sintering and products no longer on the
desired size scale. However, the crystallites to be grown on the nanoscale are much
smaller in comparison and therefore were predicted to be afforded at lower processing
temperatures. The synthesis of sub-100 nm LSO particles was attempted thru a modified
core-shell method and an annealing profile was conducted. PXRD of the powders show
only peaks characteristic of lutetium oxide (Lu2O3)28 were present in the products of the
particles annealed in the 900-1200 °C temperature range, indicating that the solid state
reaction between the silica core and Lu2O3 shell did not occur in this range (Figure 2.3).
The LSO phase was formed at 1300 °C, but the product also contained unreacted Lu2O3
as indicated by the relative peak intensity of the diffraction peaks due to both Lu2O3 and
LSO compared to the diffraction peaks specific for LSO. For example, both Lu2O3 and
LSO produce a diffraction peak at 30 nm 2 Θ which has over double the intensity of the
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peak at 33 nm 2 Θ which is due solely to diffraction from the LSO lattice. While the
particles retained the desired spherical morphology after being annealed at 1000 °C
(Figure 2.3-a), sintering of the particles to micron sized aggregates was observed at
higher annealing temperatures such as 1300 °C (Figure 2.3-b).

Figure 2.3 PXRD of lutetium containing core shell nanoparticles annealing profile (left).
SEM images of Lu2O3 nanoparticles annealed at 1000 °C for 2 h (a) and LSO
nanoparticles annealed at 1300 °C for 2 h (b).

Due to the need to produce sub-100 nm particles an additional silicon source in
the form on a silica shell was added to the nanoparticles as a possible means to trigger the
solid state reaction at lower temperatures. It was hoped that the silica coating would
provide more contact area between the lutetium and silicon providing a means to further
enable the mutual diffusion reaction. The silica was precipitated onto the particles after
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the second step of the core-shell synthetic process using tetraethoxysilane (TEOS) and
NH4OH. This synthetic route with the addition of TEOS produced the LSO phase at
1000 °C, the lowest temperature thus far achieved. However, the PXRD of the product
showed significant amorphous character indicating incomplete conversion of the silica to
the crystalline silicate phase (Figure 2.4). In addition, scanning electron microscopy
(SEM) of the product showed a pronounced “gluing” of the particles. This was thought to
be due to a polymeric effect of the excess silica coating.29 Although LSO is an efficient
scintillator as a bulk single crystal it was not found to be advantageous for use in
optogenetics, because of its high processing temperatures. Therefore synthetic efforts for
nano-scintillator production were turned towards yttrium orthosilicate (YSO), which can
be afforded at lower processing temperatures.

Figure 2.4 PXRD (left) and SEM (right) of LSO nanoparticles synthesized with SiO2
shell annealed at 1000 °C for 2 h.
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2.3.2 Yttrium Orthosilicate (YSO)
Yttrium orthosilicate (YSO), Y2SiO5, is of interest as a potential nano-scintillator
as its bulk production typically requires lower processing temperatures than Lu2SiO5, yet
is still known to produce high light output under X-ray radiation.30,31 Therefore, yttrium
orthosilicate nanoparticles were targeted using the modified core-shell synthesis.

Figure 2.5 PXRD of core-shell reaction pathway (left). SEM of Ce:YSO particles (right).
The proposed reaction pathway of the core-shell yttrium orthosilicate
nanoparticles involves the formation of a hydrated yttrium hydroxide amorphous layer
that crystallizes to form the Ce:Y2O3 shell on the silica core when heated to a sufficient
temperature. Powder X-ray diffraction measurements of the particles’ evolution supports
the proposed pathway (Figure 2.5). The nanoparticles remain completely amorphous
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after drying at 120 °C as indicated by the broad diffraction peak. The diffraction peaks,
after annealing at 900 °C, are characteristic of the crystalline Y2O3 phase.32 Finally, the
solid state reaction is evident after annealing at 1000 °C as only the Y2SiO5 phase is
present in the diffraction pattern.33
A preliminary thermal profile was conducted of the core-shell nanoparticles to
elucidate the temperature that would enable a solid state reaction between the silica core
and Y2O3 shell producing highly crystalline, phase pure orthosilicate, while maintaining
sub-100 nm size. Results showed initiation of the YSO phase after annealing at 1000 °C.
Further annealing studies were conducted at higher temperatures and longer heating times
to invoke larger crystallite sizes. On the other hand, in order to reduce aggregation of
particles during annealing, lower temperatures and shorter heating times were also
investigated. The results are given in Table 2.1. Full conversion to the YSO phase and
good retention of nanoparticle morphology was achieved by heating the core-shell
particles at 1000 °C for 2 h.

Table 2.1 Annealing Studying of Ce:YSO Core Shell Particles
Temperature
(°C)

Time
(h)

Product

Relative
Agglomeration

900

2

Y2O3

low

950

2

Y2O3

low

1000

2

Y2SiO5

low

1000

8

Y2SiO5

high

1000

0.25

Y2O3 + Y2SiO5

low
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1100

2

α , β Y2SiO5

high

2.3.3 Photoluminescence Investigation
Photoluminescence (PL) measurements of the cerium doped yttrium orthosilicate
(Ce:YSO) core-shell nanoparticles were obtained as a preliminary assessment of the
material’s optical properties. The absorption spectra of the Ce:YSO particles contains two
bands, a large one centered around 360 nm and a smaller one at 270 nm. The absorption
bands can be attributed to the excitation of an electron from cerium 4f1 ground state to
different 5d excited states.34 The emission spectra of Ce:YSO nanoparticles under
360 nm excitation showed a broad band from 400 nm to 550 nm, centered at 430 nm
(Figure 2.6). The concentration of the cerium dopant was varied from 0-10 mol% in
effort to optimize the PL intensity. 0.75 mol% cerium concentration in the Ce:YSO
nanoparticles exhibited the highest PL intensity. The decrease in PL intensity with
increasing cerium concentrations above 0.75 mol% was likely due to concentration
quenching and further more a cerium solubility limitation.35
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Figure 2.6 Cerium 3+ energy level diagram (left). Excitation and emission spectra of
Ce:YSO nanoparticles (middle). Emission spectra of cerium doped YSO nanoparticles at
indicated cerium concentrations under UV excitation (right).
The photoluminescence of the optimized Ce:YSO nanoparticles was compared to
standard commercial powders of Ce:YSO and Ce:LSO (Figure 2.7). The intensity of the
Ce:YSO nanoparticles is within 80 % of the commercial Ce:LSO powder and 90 % of the
Ce:YSO powder. The emissions of the standard powders are both broader than the
emission from the nanoparticles. This could be due to more visible emission from Ce3+ in
both unique rare earth positions as opposed to emitting from the one dominant position in
the nanoparticles.17,36 The standard commercial powders are produced at much higher
temperatures which could allow for cerium to dope into even the unfavored rare earth
position.

Figure 2.7 Emission spectra of 0.75 % Ce:YSO nanoparticles annealed at 1000 °C for
2 h compared to standard commercial powders of Ce:YSO and Ce:LSO under UV
excitation.
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2.3.3.1 Additional Y2O3 Shells
One method attempted to increase PL intensity was the layering of multiple Y2O3
shells onto the silica core. Additional yttrium containing shell layers were precipitated
onto the nanoparticle in effort to fully convert the non-luminescent silica core to the
luminescent orthosilicate phase. Optimization of the layering was carried out by varying
the cerium concentration of the layers and the number of additional yttrium containing
coatings. The double layered Ce:YSO particles with a 6 mol% cerium first shell and
undoped second shell exhibited the most intense luminescence (Figure 2.8). This could
be due to the reduction of surface quenching produced by the protective undoped layer.37
The triple coated 2 mol% Ce:YSO particles showed the lowest luminescence intensity.
This is most likely due to the layers not fully converting from yttrium oxide (Y2O3) to
yttrium orthosilicate (Y2SiO5). Cerium emission is quenched in Y2O3 and therefore when
the nanoparticles are partially of the Y2O3 phase the luminescence will be diminished.
The presence of unreacted Y2O3 was observed in the PXRD of the multiple layered
products (Figure 2.8). The PXRD pattern calculated from reported single crystal data of
Y2SiO5 contains two peaks at approximately 28 and 29 degrees 2 Θ. The Y2O3 phase
contains a strongly diffracting peak at 28 nm in the PXRD calculated from reported
single crystal data. As the amount of the unreacted yttrium oxide increases in the
nanoparticle product the definition of the two orthosilicate peaks is reduced due to the
overpowering Y2O3 peak from its strong diffraction.

46

Figure 2.8 PXRD (left) and emission spectra under UV excitation (right) of labeled
various shell layers of Ce:YSO nanoparticles.

Figure 2.9 PXRD of doubly layered core-shell particles annealed at indicated
temperatures (left). SEM image of double layered core-shell particles annealed at
1000 °C for 2 h (right).
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Different annealing conditions were applied to the double layered Ce:YSO
nanoparticles to improve conversion to the orthosilicate phase. The approximate
percentage of Y2SiO5 to Y2O3 of the double layered nanoparticles were calculated from
the collected PXRD data using the reference intensity ratio (RIR) from the PDXL:
integrated X-ray powder diffraction software. The single shell Ce:YSO nanoparticles
annealed at 1000 °C for 2 h was calculated to be 95 % Y2SiO5 in the P21/c phase. In
comparison, the Ce:YSO nanoparticles with two shells annealed under the same
conditions yielded a product with only 59 % Y2SiO5 phase while the remaining product
was Y2O3 (Figure 2.9). Increasing the annealing time from 2 h to 4 h increased the
production of the orthosilicate phase by a few percent to 62 %. However, increasing the
annealing temperature from 1000 °C to 1050 °C increased the desired orthosilicate phase
to be roughly 78 % of the product. Layering additional coats of Y2O3 showed some loss
of spherical morphology in the nanoparticles (Figure 2.9).
2.3.3.2 Mixed GYSO and LYSO
Another method tested in effort to increase luminescence intensity without
forfeiting morphology involved the addition of heavier rare earth ions to produce mixed
gadolinium/yttrium orthosilicate (GYSO) and lutetium/yttrium orthosilicate (LYSO)
nanoparticles. The mixed rare earth systems were targeted to combine the high density
and high atomic number of gadolinium and lutetium with the lower processing
temperatures of yttrium.
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Figure 2.10 PXRD of 6 % cerium doped mixed Y50L50SO nanoparticles annealed at
1000 °C for 2 h.
Initial mixed yttrium/lutetium reactions were carried out with a 1:1 molar ratio,
which produced the orthosilicate phase after heating at 1000 °C for 2 h (Figure 2.10).
However, a change to the particle morphology was observed in the finished product. The
photoluminescence intensity of the mixed Ce:YLSO nanoparticle also significantly
decreased in comparison to the Ce:YSO nanoparticles (Figure 2.11). Various
concentrations of lutetium (20 mol%, 40 mol%, 60 mol%, and 80 mol%) into the
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Ce:YSO lattice were synthesized and their photoluminescence intensities compared. In
all cases the mixed Ce:YLSO exhibited lower intensity emission compared to the
Ce:YSO nanoparticles. This could be due to the increase of defects in the crystalline
lattice caused by the substitution of the smaller Lu3+ ion into the Y3+ positions.

Figure 2.11 Comparison of emission intensity under UV excitation of Ce:YSO vs
Ce:Y50L50SO core shell particles (left) and SEM image of Ce:Y50L50SO nanoparticles
annealed at 1000 °C for 2 h (right).

Similarly, the orthosilicate phase was produced after annealing at 1000 °C for 2 h
in the mixed gadolinium/lutetium reaction when a 1:1 molar ratio was used (Figure
2.12). The final GYSO product contained more of the desired morphology as compared
to the LYSO particles, however less than that of the solely yttrium containing
nanoparticles. Different molar ratios of gadolinium to yttrium (Gd10Y90, Gd25Y75,
Gd50Y50, Gd75Y25, and Gd90Y10) were synthesized via the core-shell method. The PXRD
of the mixed gadolinium/yttrium powders show a phase change corresponding to the
amount of gadolinium present in the reaction. A silicate apatite phase was produced at
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higher concentrations of gadolinium (Gd90Y10 and Gd75Y25), while the orthosilicate phase
resulted from concentrations of 50 mol% gadolinium and lower (Figure 2.13). The
apatite phase in space group P63/m has been reported in bulk forms of gadolinium
silicates and contains a partial rare earth vacancy.38,39 The photoluminescence of the
mixed gadolinium/yttrium silicates showed a trend of increasing emission intensity with
decreasing gadolinium concentration. The ratios that produced the apatite phase (Gd90Y10
and Gd75Y25) exhibited exceptionally low photoluminescence which can be attributed to
nonradiative decay caused by the partial rare earth vacancy present in the apatite phase.
This change in structural chemistry involving gadolinium host ions is quite complex and
discussed in greater detail in following chapters.

Figure 2.12 PXRD (left) and SEM (right) of 6 % cerium doped mixed Y50Gd50SO
nanoparticles annealed at 1000 °C for 2 h.
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Figure 2.13 PXRD (left) and emission spectra under UV excitation (right) of mixed
cerium doped gadolinium/yttrium silicate nanoparticles.
2.3.3.3 Annealing in a Reducing Atmosphere
Cerium is one of a limited number of rare earths that has an additional stable
oxidation state, other than 3+.11 Ce3+ has been reported to oxidize to Ce4+ easily in
materials that are annealed in air specially at high temperatures.40 Ce4+ has an electron
configuration of [Xe]4f0 and therefore is not readily luminescent. The hypothesis was that
the presence of Ce4+ would reduce the desired optical properties of the material. In order
to keep the cerium reduced to its 3+ oxidation state after drying the precursor power was
annealed in a reducing atmosphere of 5 % H2:N2 gas mixture. The product matched the
characteristic diffraction of the yttrium pyrosilicate (Y2Si2O7) phase41 instead of the
targeted orthosilicate phase and exhibited a reduction in luminescence (Figure 2.14).
Reduced annealing was not further pursued for radioluminescence studies of the cerium
doped orthosilicates, due to the pyrosilicate formation. Additionally, the literature
suggests that some amount of Ce4+ benefits scintillation of cerium doped orthosilicate
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materials. Blahuta et al. proposed a mechanism by which Ce4+ acts as an electron trap
producing an excited Ce3+ species, that then can have radiative de-excitation to the
ground state accompanied by photon emission (Figure 2.15). 42,43

Figure 2.14 PXRD of yttrium core-shell nanoparticles annealed at 1000 °C for 2 h in a
reducing atmosphere of 5 % H2:N2 gas mixture.
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Figure 2.15 Scheme of proposed pathway of visible light emission from Ce4+
contamination in cerium doped rare earth orthosilicate crystalline material.
2.3.4 Radioluminescence Investigation
Radioluminescence (RL) measurements were carried out on the Ce:YSO
nanoparticles. The X-ray radioluminescence of the cerium doped YSO nanoparticles was
broader and red shifted roughly 90 nm compared to the photoluminescence emission
from the same material (Figure 2.16). The broad emission brand is centered around
520 nm as opposed to 430 nm when under UV excitation. This broadening and shift is
possibly due to the high energy X-rays exciting both unique rare earth positions within
the orthosilicate structure.16,44 The dopant concentration effect on emission intensity
showed a similar trend under X-ray excitation respective to when exposed to UV
excitation. Again, lower concentrations of cerium exhibited greater emission intensity.
The Ce:YSO nanoparticles had a radioluminescence intensity slightly less than 1/8 of the
commercial Ce:LSO standard. Since crystallite size plays such a significant role in the
efficiency of scintillators,6 these results are particularly impressive when considering that
the nanoparticles have crystallite sizes roughly 100 times smaller than the standard bulk
material to which they were compared and was viewed as a promising start for
subsequent optimization.
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Figure 2.16 Radioluminescence emission profile of 2 % Ce:YSO nanoparticles annealed
at 1000 °C for 2 h (left) and compared to a standard commercial powder of Ce:LSO
(right).
2.3.5 Azide Functionalization
The end goal of this project involves injecting the scintillating nanoparticles into
the bloodstream and having them targeted to specific neurons in the brain. In order to
achieve this goal the Ce:YSO nanoparticles were functionalized with azide surface
moieties. Azide functionalization was chosen because it can enable the use of “click”
chemistry45 which would open the door to a multitude of functionalization options to be
used in targeting and biocompatibility. These future directions are discussed in more
detail in Chapter 6. The azide functionality was accomplished by the hydrolysis and
condensation of an 3-azidepropyltrimethoxysilane onto the Ce:YSO nanoparticles. A 3azidepropyltrimethoxysilane was synthesized by nucleophilic substitution of a chloride
with an azide using 3-chloropropylmethoxysilane and sodium azide staring materials.
The azide functionality was confirmed using FTIR spectroscopy with the azide stretching
appearing at 2100 cm-1 (Figure 2.17). The functionalized Ce:YSO nanoparticles retained
spherical morphology and can be further functionalized in a facile manner using “click”
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chemistry. This proof of concept azide functionality can be transferred to other nanoscintillators as a general first step to adjusting targeting and biocompatibility of the
nanoparticles.

Figure 2.17 IR spectra of uncoated Ce:YSO nanoparticles and azide modified Ce:YSO
nanoparticles (left) and SEM image of azide modified Ce:YSO nanoparticles (right).
2.3.6 MTS Assay
As more and more nanoparticles enter into biological systems it is important to
factor in the possibility of toxicity issues. Cell culture studies account for the majority of
all nanotoxicological research and are important data, however further testing including
in vivo analysis is required to make substantial toxicity claims about nanoparticles. There
are a number of reasons for this including reported disagreement between in vitro and in
vivo toxicity results. Additionally, it is possible that nanoparticles interfere with the
instrumentation used to assess cell viability assays. Lastly, the influence of transport
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cannot be readily evaluated from in vitro studies. All this is not to say that cell assays do
not provide valuable cell type specific responses.
It is hard to pin point toxicity on one parameter of a nanoparticle as so many need
to be taken into consideration including dose, structure, size, shape, surface charge, and
opsonization. Additionally, the amount, types, and ways in which biological materials
absorb to the surface of the nanoparticle will have a significant role on their viability. It is
recommended to evaluate each nanoparticle separately rather than to form generalizations
of the parameter. Silica nanoparticles have undergone several in vitro and in vivo toxicity
studies by a number of research groups for various biomedical applications and have
been deemed generally bio-inert.46–49 Therefore, SiO2 nanoparticles are commonly used
as a standard of comparison in nanoparticles toxicity studies.
As a preliminary toxicity assessment MTS assays were performed on the SiO2
nanoparticles, Ce:YSO nanoparticles, and Ce:LSO commercial standard powder
(Figure 2.18). SiO2 nanoparticles were tested as a proof of concept as they have been
reported to be biologically inert.48 The particles were incubated with normal human
dermal fibroblast (NHDF) cells for 72 h. The data was collected in triplicate. The
viability of the untreated cells was normalized to 100 % in order to compare the viability
of the cells exposed to the nanoparticles. The Tukey’s test was run on the viability data.
The results showed that there was not a statistically significant difference between the
untreated cells and the cells that were exposed to any of particles up to highest tested
concentration (3.60×109 particles/mL).
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Figure 2.18 MTS assays of normal human dermal fibroblast (NHDF) cells incubated
with SiO2 nanoparticles, Ce:Y2SiO5 (Ce:YSO) nanoparticles, and Ce:Lu2SiO5 (Ce:LSO)
commercial standard powder in concentration of 3.60×107 particles/mL,
3.60×108 particles/mL, and 3.60×109 particles/mL for 72 h.
2.3.7 Biodistribution and Immune Response
After promising initial radioluminescence and cytotoxicity studies, the Ce:YSO
nanoparticles were sent to collaborators at the University of New Mexico for
biodistribution and immune response testing. Extensive details of the biodistribution and
immune response methods including experimental subjects, microinjection of the
nanoparticles, immunohistochemistry, and confocal microscopy have been published by
Fischer et al.50 Briefly, 3 mg/mL fluorescein labeled Ce:YSO nanoparticles dispersed in
saline solution were injected into the secondary motor cortex (M2) of six month old mice.
At 24 h, 72 h, and 9 days post injection mice were sacrificed and 50 μm coronal brain
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slices were collected and prepped for analysis. In order to determine biodistribution of the
injected particles confocal imaging of the fluorescein labeled Ce:YSO was taken across
the entire M2 region. The fluorescence from the nanoparticles adjacent to the injection
site decreased to baseline by day 9 post injection. The overall fluorescence signal
remained unchanged in the tested time period and therefore indicates that the particles
passively diffuse from the injection site but remain within the brain tissue.
Additionally, the tissue was stained for immune response indicators; a microglial
marker (IBA-1) and an astrocyte marker (GFAP). The results suggested an immune
response was initially mounted against the injected nanoparticles. However, the increased
presence of IBA-1 and GFAP returned to baseline after the 72 h and 9 day time points
respectively and the immune response was normalized. These results suggest that no
permanent injury was obtained from the nanoparticle injection or from the presence of
the nanoparticles themselves.

2.4 Summary and Conclusions
Ce:YSO nanoparticles and Ce:GYSO, Ce:LYSO, and Ce:LSO particles were
produced through a core-shell synthetic route. In this method silica nanoparticles were
used as cores in order to provide a morphology template as well as the silicon needed for
the final orthosilicate phase. The rare earth was precipitated onto the silica core and
annealed to form a crystalline rare earth oxide shell. Further annealing produced a solid
state reaction between the silica core and rare earth shell generating silicate phase
products. The Ce:YSO nanoparticles were readily producible as 80 nm dispersible
spheres and therefore were further tested as potential nano-scintillators for optogenetics.
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Photoluminescence and radioluminescence measurements were gathered for the Ce:YSO
nanoparticles. The Ce:YSO nanoparticles show roughly 1/8 the emission intensity under
X-ray excitation compared to a standard commercial Ce:LSO powder. Initial
biocompatibility studies were conducted. The Ce:YSO did not show toxicity in contact
with NHDF cells for up to 72 h under the highest tested concentrations. Additionally, it
was found that Ce:YSO nanoparticles injected into mice brains passively diffuse from the
injection site, but remain within brain for the tested time period. Initial immune response
to the injection was observed but returned to baseline by day 9 post inject. The Ce:YSO
nanoparticles are promising nano-scintillators for optogenetics. In order to continue to try
to increase the radioluminescence targeting a heavier rare earth such as gadolinium
orthosilicate was attempted and will be discussed in the following chapter.
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CHAPTER THREE
SYNTHESIS AND OPTICAL CHARACTERIZATION OF
CERIUM-DOPED GADOLINIUM AND MIXED
GADOLINIUM/LUTETIUM SILICATE NANOPHOSPHORS
3.1 Introduction
Nanophosphors have been shown to be useful in many biomedical applications
including biolabeling,1 imaging,2 photodynamic therapy,3 and optogenetics.4 One
limitation of the current technology is the penetration depth of the excitation wavelength
used to activate the nanophosphors. This limitation has led to the demand for radiation
that has deeper penetration and materials that can convert the high energy radiation into
visible light for many of the emerging biomedical efforts. Recently upconverting
nanoparticles have been studied to help mitigate this problem as they can be activated
with infrared (IR) radiation. This is particularly useful for biomedical applications as IR
wavelengths exhibit less scattering from tissue components and are not absorbed as
readily by endogenous chromophores as compared to visible light.5,6 However, there are
still depths of interest that cannot be reached by IR radiation. In order to meet new
technological demands, X-rays in conjunction with nano-scintillators, that are able to
absorb the high energy radiation and convert it to visible light, were proposed to further
penetration depth. In order to do so a family of rare earth silicate nanoparticles were
synthesized to be used as nano-scintillators suitable for optogenetics applications.
Rare earth silicates are some of the most studied scintillating materials and are
regularly produced for industrial purposes such as in computed tomography (CT) and
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positron emission tomography (PET) scanners for medical imaging,7,8 nuclear security,9
and nuclear plant safety.10 Hydrothermal,11,12 solid state,13 and sol-gel14 syntheses have
been reported to produce rare earth silicates in various forms including powders,
ceramics, and single crystals. Lutetium orthosilicate (LSO), Lu2SiO5, is one of the most
promising scintillating materials due to its high density, high atomic number, and
refractory properties.15 However, as discussed in the previous chapter the high processing
temperatures required to produce lutetium orthosilicate leads to the formation of large,
sintered particles. Conversely, optogenetics applications require nanoparticles that are
under 100 nm, dispersible, and uniform in shape and size. These demands represent a
considerable synthetic challenge for LSO as the high processing temperatures required
lead to aggregation of the nanoparticles. Gadolinium orthosilicate (GSO), Gd2SiO5, is of
interest as a nano-scintillator target, because its bulk production typically requires lower
processing temperatures than LSO, yet is still known to produce high light output under
X-ray radiation.16,17 Therefore, gadolinium silicate nanoparticles were targeted using a
modified core-shell synthesis.
Traditionally, the components of core-shell nanoparticles do not chemically
interact. The core is generally used as a template in order to achieve a desired shape and
size and the shell material possesses the physical property of interest.18–20 Yermolayeva
et al.21 have reported a core-shell synthetic method such that the core and shell are used
as reactants to form a different compound. They were able to produce lutetium
pyrosilicate (LPS), Lu2Si2O7, as 300-500 nm particles using the core-shell synthesis.
Recently, Egodawatte et al.22 published the synthesis of 100 nm LPS nanoparticles using
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a core-shell synthesis and salt supported high temperature method; while this is an
impressive result, the nanoparticles had remaining unreacted oxides that diminish
radioluminescence output. In the current work, the core-shell process was adapted, by
targeting silicates with lower processing temperatures such as gadolinium silicates, to
produce sub-100nm spheres of phase pure rare earth orthosilicates.
In this thesis work expansion of the limited nano-scintillator literature was
accomplished by exploring the rich phase chemistry of gadolinium silicates. Effects of
pH and heat treatment on the structure and morphology of the particles were investigated.
Reactant ratio manipulations enabled clean control and switching between the gadolinium
silicate phases orthosilicate Gd2SiO5 (GSO), pyrosilicate Gd2Si2O7 (GPS), and an apatite
phase Gd4.67(SiO4)3O (GSAP), at the nanoscale. Most impressive, the particles were
under 100 nm and remained dispersible and uniform for all silicate phases produced.
Furthermore, lutetium was added to the gadolinium silicates as a means to improve
radioluminescence intensity. The mixed gadolinium/lutetium (Gd/Lu) silicates produced
retained uniformity and dispersity while also drastically increasing the radioluminescence
intensity output of the nano-silicates.

3.2 Experimental
3.2.1 Materials
All materials were obtained from commercial suppliers and used without further
purification. Ethanol (EtOH 98 % water solution), tetraethyl orthosilicate (TEOS,
99.9 %),

urea

(CH4N2O,)

(NH4OH

30
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%

water

solution),

cerium

nitrate

(Ce(NO3)3 · 6H2O), gadolinium nitrate (Gd(NO3)3 · x H2O, 99.9 %), lutetium nitrate
(Lu(NO3)3 · x H2O, 99.99 %).
3.2.2 Core-Shell Synthesis
The

cerium

doped

gadolinium

and

mixed

gadolinium/lutetium

silicate

nanoparticles were synthesized via a core-shell method23 as illustrated in Figure 3.1. The
70 nm silica nanoparticles were first synthesized using a modified Stöber method.24
Wherein, TEOS is hydrolyzed in ethanol in the presence of ammonium hydroxide as a
catalyst with a molar ratio of TEOS:NH4OH:H2O of 1.00:1.30:7.00. After allowing the
solution to stir for 24 h the resulting silica particles were separated by centrifugation,
washed with ethanol and water, and dried overnight at 85 °C.

Figure 3.1 Schematic of core-shell synthetic process.
The rare earth shell was deposited onto the silica core using a core-shell synthetic
route.23 First, freshly prepared silica was dispersed in a water solution containing the rare
earth nitrate starting materials via sonication. The solution was then heated to 85 °C and
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stirred for 20 min before 6 g of urea was added. The solution was then continued to heat
and stir for 4 h. The resulting particles were separated by centrifugation, washed several
times with ethanol and water, and dried at 125 °C. The dried particles appeared as
powders in varying degrees of yellow depending on the amount of cerium doped into the
reaction.
Lastly, the amorphous core-shell particles were thermally treated in air in a
temperature range of (900-1200 °C) for 2 h. There was an observed reduction in the
yellow color of the nanocrystalline powders following the heat treatment. The obtained
core-shell nanoparticles were spherical with approximate diameters of 80 nm as shown in
Figure 3.2.

Figure 3.2 SEM images of Ce:Gd4.67(SiO4)3O (a), Ce:Gd2SiO5 (b), Ce:Gd2Si2O7 (c), and
Ce:G50L50SO (d) annealed at 1000 °C for 2 h. White scale bar is 200 nm for all above
images.
3.2.3 Preparation of Ce:Gd4.67(SiO4)3O, Ce:Gd2SiO5, and Ce:Gd2Si2O7 Nanoparticles
Cerium doped gadolinium orthosilicate (Ce:Gd2SiO5) nanoparticles were
produced via the core-shell synthesis described above using a molar ratio of 2:1 of rare
earth nitrate (RE(NO3)3) to silica (SiO2) starting materials. For a typical synthesis, 1.53 g
of RE(NO3)3 · 6H2O was dissolved in 90 mL H2O. Then 0.12 g of freshly prepared
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Stöber silica nanoparticles was added to the nitrate solution and dispersed via sonication.
After the resulting mixture was heated to 85 °C for 20 min, 6 g of urea was added and
continued to be heated for 4 h. The particles were separated using centrifugation and
washed several times with water and ethanol and then dried overnight at 125 °C. The
dried powder was annealed at 1000 °C for 2 h to obtain the silicate phases. The final
phase of gadolinium silicate nanoparticles was manipulated by varying the ratio of the
gadolinium to silicon starting materials as shown in Table 3.1. Additionally, the
concentration of cerium dopant also affected the final phase of the silicate species formed
and is described further in the results and discussion section.

Table 3.1. Gadolinium Silicate Reaction Schemes.
Scheme
1
2
3

Reactant Ratio and Product
2 Gd(NO3)3 + 1 SiO2
1 Gd(NO3)3 + 1 SiO2
1 Gd(NO3)3 + 2 SiO2

Temperature

Gd2SiO5

1000 °C

Gd4.67(SiO4)3O

1000 °C

Gd2Si2O7

1000 °C

3.2.4 Preparation of Mixed Cerium Doped Gadolinium/Lutetium Silicate
Nanoparticles
Mixed gadolinium/lutetium orthosilicate nanoparticles were synthesized using the
previously described core-shell synthesis. Gd(NO3)3 and Lu(NO3)3 were dispersed in the
same water solution before the silica precursor was introduced to the mixture. As with the
gadolinium system the final silicate phases of the mixed gadolinium/lutetium particles
could be manipulated by varying the starting material ratios. As a specific example 0.9 g
of Gd(NO3)3· 6H2O and 0.94 g of Lu(NO3)3 · 6H2O were dissolved in 90 mL H2O. 0.12 g
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of silica was added to the solution and sonicated. The solution was then heated to 85 °C
for 20 min before 6 g urea was added. The reaction was allowed to continue for 2 h. The
product was recovered via centrifugation, washed several times, and then dried overnight
at 125 °C.

A 1:1:1 molar ratio of Gd(NO3)3 to Lu(NO3)3 to SiO2 produced the

orthosilicate phase after annealing at 1000 °C for 2 h. Further description of phase
manipulation in this mixed system is presented in the results and discussion section.
3.2.5 Characterization of Nanophosphors
Scanning electron microscopy (SEM) was used to study morphology and particle
size of the core-shell particles. Particles to be imaged were dispersed in water and waterbath sonicated before being deposited onto carbon tape dropwise. After drying at 85 °C
the samples were sputter coated with platinum for 1 min. A Hitachi S4800 field emission
scanning electron microscope was used to produce images with an accelerating voltage of
20 kV.
Samples were dissolved in concentrated nitric acid and then diluted to 5 % nitric
solution for inductively couple plasma – optical emission spectroscopy (ICP-OES)
measurements to determine the Ce3+ dopant concentration present in the final gadolinium
silicate nanoparticle products.
Careful monitoring of the particle characteristics was accomplished by using
powder X-ray diffraction to identify the core-shell reaction pathway, crystallinity, phase
purity, and crystal domain size. The PXRD measurements were obtained using a Rigaku
Ultima IV equipped with CuKα radiation (λ = 1.5406). The diffraction data were recorded
over a 2 θ range of 5 ° to 65 ° in 0.2 ° increments with a scan speed of 1 °/min. The
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average crystallite sizes of the core-shell particles were calculated using the broadening
of the PXRD lines in accordance with the Scherrer equation: t = K λ/(β cos θ), where λ is
the X-ray wavelength, K is dimensionless shape factor, β is the broadening at half the
maximum intensity of the line sited at θ angle.
For luminescence measurements 20 μg of the particles were dispersed in PDMS
films. The films were made in triplicate for each sample. Commercial Ce:LSO powder
purchased from Phosphor Technologies, with an average particle diameter of 8 μm, was
similarly prepared into films and used as a standard of comparison for emission intensity.
The photoluminescence spectra of the core-shell particles were obtained using a Jobin
Yvon Fluorolog 3-222 spectrometer with double grating configuration and xenon lamp
source. The measurements were performed with a 3 nm slit width and scan speed of
0.1 nm/sec. The radioluminescence spectra of the core-shell particles were obtained by
irradiating the sample with a tungsten source mini X-ray tube (Amptek Inc.), operating at
a tube voltage of 50 kV and a tube current of 79 μA. The radioluminescence was
collected with a fiber bundle (Oriel) coupled to a MicroHR (Horiba Jobin Yvon)
monochromator and a cooled CCD detector (Synapse, Horiba Jobin Yvon).
3.2.6 MTS Assay
The Human Embryonic Kidney (HEK) cells were obtained from ATCC and
cultured at 37 °C in a humidified atmosphere of 95 % air / 5% CO2. The HEK cells were
cultured in Dulbecco’s modified Eagle’s media (DMEM) containing 10 % FBS and 5 %
L-glutamine. The cells were plated for 72 h at 7,000 cells per well in a 96 cell well plate.
The cells were separately incubated with the Gd2SiO5 (GSO), Gd2Si2O7 (GPS),
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Ce:Gd4.67(SiO4)3O (GSAP), and (GdLu)2SiO5 (GdLuSO) particles in concentrations of
3.60×107 particles/mL, 3.60×108 particles/mL, and 3.60×109 particles/mL. After 72 h of
incubation with the rare earth silicate nanoparticles the cells’ viability was measured
using MTS assay (CellTiter 96 AQueous One Solution Cell Proliferation Assay, Promega)
following the manufacturer’s instructions. The particles and media were removed from
the cells and replaced with 200 μL of DMEM media and 40 μL of the MTS tetrazolium
reagent. The MTS solution was incubated with the cells for 3 h. The absorbance was
measured using a plate reader at OD = 490 nm. The data was collected in triplicate.

3.3 Results and Discussion
3.3.1 Process
The nanophosphors were manufactured through the previously described coreshell method. Reaction condition optimization and heating protocol studies were carried
out to identify conditions which produced highly crystalline and phase pure particles
while maintaining the desired morphology. The rare earth shell was coated onto the silica
core under moderately basic conditions. A correlation between pH of the reaction mixture
and the morphology of the particles was observed. The higher the pH the more
aggregation was observed in the product. A relatively low pH produced uniform,
dispersible spheres, however too low of a pH led to poor phase formation. This is shown
in the largely amorphous products presented in the first two spectra of Figure 3.3. A
certain level of basicity must be reached in order to have adequate deposition of the rare
earth materials onto the silica nanoparticles. A pH around 9 in the reaction mixture was
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found to produce good phase formation while preserving the preferred particle
morphology.

Figure 3.3 PXRD data of Ce:Gd4.67(SiO4)3O particles synthesized under the indicated pH
conditions.
Figure 3.4 displays the powder X-ray diffraction (PXRD) data of the core-shell
particles heated for 2 h in air at the indicated temperatures. The samples remained
amorphous up to 900 °C after which the diffraction peaks all match that of Gd4.67(SiO4)3O
as reported in the ICSD.25 No additional phases were observed in the PXRD data at higher
heat treatment temperatures. Further analysis of the diffraction data using the Scherrer
equation showed an increase in crystallite size from 16.3 nm to 52.5 nm with an increase
in annealing temperature from 900 °C to 1200 °C. It should be noted that scintillation is a
complex multistep process with photons migrating through the lattice, so any grain
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boundaries in the crystallites cause nonradiative decay and decreasing efficiency.26
Therefore bulk crystals and larger sized crystallites generally show much better
scintillation properties than nanoparticles. The proposal of optogenetic applications
however, require nanoparticles at or below 100 nm in diameter, consequently higher
annealing temperatures that induce formation of sintered agglomerates were not pursued.

Figure 3.4 PXRD data of Ce:Gd4.67(SiO4)3O particles annealed at the indicated
temperatures for 2 h in air.
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3.3.2 Silicate Phase Manipulation
The final phase of the nanoparticles was manipulated by adjusting the starting
material ratio and dopant concentration. The PXRD in Figure 3.5 shows the precision of
the nanocrystalline gadolinium phase transitions. When the rare earth to silicon starting
material was held constant the phase of the final product was influenced by varying the
concentration of cerium dopant. When no cerium was added the particles crystallized in
the orthosilicate phase. The pyrosilicate phase was observed when low concentration of
cerium was doped into the structure and syntheses with concentrations of 1 mol% and
greater of cerium starting material led to the formation of the apatite type phase as
depicted in Figure 3.6.

Figure 3.5 PXRD spectra of the Ce:Gd2SiO5 particles (a), Ce:Gd4.67(SiO4)3O particles (b),
and Ce:Gd2Si2O7 particles (c), along with their corresponding calculated powder patterns.
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Figure 3.6 PXRD data of the core-shell particles synthesized with various amounts of the
cerium dopant.
Inductively coupled plasma optical emission spectroscopy (ICP -OES) was used
to verify the cerium dopant concentration in the gadolinium nano-silicates. As shown in
Table 3.2, the nominal concentration of cerium matches closely with the concentration
found in the final product.
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Table 3.2 Ce3+ Concentration in Gadolinium Silicate Nanoparticles.
Scheme

Nominal

ICP

1

0.75%

0.76%

2

1.50%

1.53%

3

3.00%

3.11%

4

6.00%

6.25%

5

10.00%

9.69%

A core-shell synthesis using a 1:1 molar ratio of silica to rare earth starting
materials produced Ce:Gd4.67(SiO4)3O, an apatite phase. Gd4.67(SiO4)3O crystallizes in
space group P63/m which is common for lanthanide containing silicate apatite species.
The structure contains two unique rare earth positions, located in a six-coordinate twisted
trigonal prism and a seven coordinate distorted pentagonal bipyramid. A partial rare earth
vacancy is found at the six coordinate rare earth position.27 As shown in the PXRD of
Figure 3.7 the apatite phase persisted through all tested concentrations of cerium dopant.
It is expected that the partial rare earth vacancy in the apatite phase plays a role in
allowing for more of the larger cerium ion to dope into the structure.
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Figure 3.7 PXRD data of Ce:Gd4.67(SiO4)3O particles at different dopant concentrations
annealed at 1000 °C for 2 h in air.
A stoichiometric ratio of rare earth to silica starting materials produced the
orthosilicate phase, Ce:Gd2SiO5 core-shell nanoparticles. Traditionally, bulk rare earth
orthosilicates crystallize in one of two polymorphs depending on the processing
temperature and the size of the rare earth ion.28 As it does in bulk form, the synthesized
nanoscale gadolinium orthosilicates preferentially crystallize in P21/c known as the
X1-Gd2SiO5 phase or the low temperature phase.29 The orthosilicate P21/c phase also
contains two unique rare earth positions with 7 and 9 coordination environments. The
orthosilicate phase was stable until 3 mol% cerium dopant, above which the apatite phase
was formed as shown in Figure 3.8.
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Figure 3.8 PXRD data of Ce:Gd2SiO5 particles at different dopant concentrations
annealed at 1000 °C for 2 h in air.
The Ce:Gd2Si2O7, pyrosilicate, nanoparticles were produced using a 1:2 of rare
earth to silica starting materials. Multiple pyrosilicate polymorphs have been reported,30
and in this case the Ce:Gd2Si2O7 nanoparticles crystallize in the triclinic space group P1� .
The structure is made of up a 1:1 ratio of an isolated orthosilicate ion and a linear

trisilicate ion interconnected with the rare earth polyhedra. The pyrosilicate phase is
unique from the phases previously discussed in that there are four unique rare earth
positions.31 Through continued reduction of the rare earth to silica starting ratio the
pyrosilicate was able to accommodate all tested concentrations of cerium as shown in
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Figure 3.9. The spherical morphology of the particles remained constant for all three
phases, however some additional aggregation was observed in the ortho- and pyrosilicate
phases.

Figure 3.9 PXRD data of Ce:Gd2Si2O7 particles at different dopant concentrations
annealed at 1000 °C for 2 h in air.
3.3.3 Addition of Lutetium
In an attempt to maximize the brightness and X-ray absorption while still
maintaining the desired orthosilicate phase lutetium was systematically added into the
gadolinium host lattice.32 Mixed gadolinium/ lutetium core-shell silicate nanoparticles
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were synthesized in the following mol% proportions Gd90Lu10, Gd75Lu25, Gd50Lu50,
Gd25Lu75, and Gd10Lu90. Figure 3.10 shows the pyrosilicate phase was obtained for all
ratios of the mixed gadolinium/lutetium particles. A designed reduction in the initial
silica concentration was conducted in attempt to achieve the strongly scintillating
orthosilicate phase. Upon doing so the product was a mixture of apatite and orthosilicate
phases. The apatite phase was formed at lower concentrations of lutetium, while when
50 mol% of lutetium was used the orthosilicate phase was incorporated and continued to
grow in as the lutetium concentration increased as shown in the PXRD of Figure 3.11.
The rare earth starting material was doubled as an additional attempt to target the
orthosilicate phase at lower lutetium ratios. By doing so the orthosilicate phase appeared
in the lowest lutetium concentration mixed particles (Gd90Lu10) and was fully resolved in
the 1:1 lutetium to gadolinium (Gd50Lu50) structure (Figure 3.12).
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Figure 3.10 PXRD data of mixed Ce:Gd/Lu pyrosilicate particles at different Gd/Lu
ratios annealed at 1000 °C for 2 h in air.
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Figure 3.11 PXRD data of mixed Ce:Gd/Lu apatite particles at different Gd/Lu ratios
annealed at 1000 °C for 2 h in air.
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Figure 3.12 PXRD data of mixed Ce:Gd/Lu orthosilicate particles at different Gd/Lu
ratios annealed at 1000 °C for 2 h in air.
3.3.4 Photoluminescence
Photoluminescence data was collected for all of the nano-silicates to examine
their brightness relative to the performance of a standard Ce:LSO bulk powder. Figure
3.13 shows the excitation and emission spectra of the as prepared Ce:GSO particles
annealed at 1000 °C for 2 h. All of the synthesized rare earth core-shell particles
exhibited similar excitation and emission profiles characteristic of cerium doped
orthosilicates.33 The broad emission peaking at 430nm is ascribed to the 5d- 4f transition
of the Ce3+ ion.
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Figure 3.13 PL and PLE of 2 % Ce:GSO particles.
A clear difference in emission intensity is observed when comparing the different
silicate phases. The Ce:GSAP nanoparticles showed weak photoluminescence in all
cases. The poor intensity was attributed to quenching due to the partial rare earth vacancy
in the apatite structure leading to nonradiative decay. In addition, the rare earth - oxygen
bond lengths are longer in the apatite structure as opposed to the orthosilicate and
pyrosilicate structures. The longer bond lengths result in a weaker crystal field around
Ce3+ in the apatite structure, which could also play a role in the decreased luminescence
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efficiency of the apatite phase. The Ce:GSO and Ce:GPS nanoparticles exhibited
relatively high photoluminescent intensity, comparable to the commercial Ce:LSO
powder. The pyrosilicate phase had slightly more intense and narrow emission compared
to the orthosilicate phase. The cerium concentration was varied in effort to optimize
photoluminescence intensity. The cerium emission remained neglectable for the apatite
phase at all dopant concentrations (0.75 mol% – 10 mol%). Three concentrations were
tested for the orthosilicate phase 0.75 mol%, 1.5 mol%, and 2 mol%. The relative
emission intensity increased as the dopant concentration was decreased. The pyrosilicate
phase showed similar emission intensity for dopant concentrations (0.75 mol% 6 mol%). A decreased was noticed when 10 mol% was used, possibly owing to
concentration quenching as shown in Figure 3.14.
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Figure 3.14 Emission spectra of Gd2Si207 particles at different cerium concentration
under UV excitation.
Photoluminescence measurements of the various mixed Gd/Lu particles displayed
the representative blue light emission of Ce3+. Although, relatively high for all the Gd/Lu
species the photoluminescence intensity of the particles varied in relation to phase as well
as the ratio of gadolinium to lutetium. The apatite mixed Gd/Lu nanoparticles showed a
general trend of increasing intensity with increasing lutetium with the exception of the
least intense ratio Gd75Lu25 falling below Gd90Lu10 (Figure 3.15.1). The orthosilicate
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mixed Gd/Lu particles showed the same general trend again with one outlier. As shown
in Figure 3.15.2 the Gd25Lu75 particles exhibited more intense emission than the
Gd10Lu90 particles. The mixed Gd/Lu pyrosilicate nanoparticles displayed the opposite
trend, the photoluminescence intensity increased with decreasing lutetium concentration
(Figure 3.15.3). Figure 3.16 compares the three different silicate phases at the Gd50Lu50
ratio. The intensity increases slightly from the apatite to the pyrosilicate to the
orthosilicate phase. Emission from the Ce:GPS nanoparticles is slightly blue shifted in
comparison to the apatite and orthosilicate emission spectra which is in agreement with
results previously reported for bulk Ce:GPS.34

Figure 3.15 Emission spectra of mixed Gd/Lu apatite (left), orthosilicate (middle), and
pyrosilicate (right) phases nanoparticles at different Gd to Lu concentrations under UV
excitation.
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Figure 3.16 Comparison of emission spectra of the mixed Gd50Lu50 apatite, orthosilicate,
and pyrosilicate phases under UV excitation.
3.3.5 Radioluminescence
All three phases of the solely gadolinium nanoparticles showed relatively low
emission under X-ray excitation. The emission spectra of the three nanocrystalline
gadolinium silicate phases as shown in Figure 3.17 have a broad, low intensity peak from
400 nm to 550 nm and a sharper, more intense peaks around 570 nm. The peak at 570 nm
is likely due to a high energy gadolinium transition and is only noticeable, because the
cerium emission is extremely dim.35–37
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Figure 3.17 Comparison of emission spectra of Ce:Gd4.67(SiO4)3O, Ce:Gd2SiO5, and
Ce:Gd2Si2O7 under X-ray excitation.
The

radioluminescence

spectra

was

also

recorded

for

the

mixed

gadolinium/lutetium particles. The emission from the mixed rare earth silicate
nanoparticles under X-ray excitation exhibited a more pronounced broad emission from
400 nm to 550 nm. This emission can be attributed to 5d to 4f cerium transition. The
mixed pyrosilicate phase resembles the gadolinium silicate spectra as it has the most
intense peak at 570 nm. The intensity of the broad cerium emission remained relatively
consistent between the different ratios of gadolinium to lutetium. Whereas, the 570 nm
peak is noticeably more intense in the Gd25Lu75 and Gd50Lu50 pyrosilicate species
(Figure 3.18).
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Figure 3.18 Emission spectra of mixed Gd/Lu pyrosilicate phase nanoparticles at
different Gd to Lu concentrations under X-ray excitation.
The orthosilicate and apatite mixed Gd/Lu X-ray excited emission spectra look
similar to each other and exhibit the characteristic Ce3+ emission. Figure 3.19 shows the
spectra of the apatite mixed rare earth system. The ratios of gadolinium/lutetium apatite
nanoparticles exhibit broad blue emission centered around 450 nm and the additional
peak around 570 nm. The Gd75Lu25 particles presented slightly different than the rest of
the mixed apatite system. The first emission peak from the Gd75Lu25 particles is red
shifted, not starting until 400 nm and centered around 520 nm. The emission intensity
increases with an increase in lutetium concentration. The radioluminescence spectra of
the orthosilicate mixed gadolinium/lutetium particles is shown in Figure 3.20. The mixed
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orthosilicate particles exhibited blue cerium emission as well as the more narrow peak at
570 nm under X-ray excitation.

Generally, both peaks increased in intensity with

increasing lutetium content from Gd90Lu10 until Gd25Lu75. The highest lutetium ratio
mixed orthosilicate particle Gd10Lu90 lies outside of the trend and exhibits less intense
emission compared to Gd25Lu75.

Figure 3.19 Emission spectra of mixed Gd/Lu apatite phase nanoparticles at different Gd
to Lu concentrations under X-ray excitation.
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Figure 3.20 Emission spectra of mixed Gd/Lu orthosilicate phase nanoparticles at
different Gd to Lu concentrations under X-ray excitation.
The radioluminescence of the rare earth silicate nanoparticles were tested against
a commercial Ce:LSO standard powder. Unfortunately, the emission intensity from the
solely gadolinium silicates was not on the same order of magnitude as the commercial
standard. However, the addition of lutetium into the lattice as well as phase manipulation
of the nano-silicates produced a systematic increase in radioluminescence intensity. The
brightest particles exhibit roughly 40 % emission intensity compared to commercial
Ce:LSO as shown in Figure 3.21.
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Figure 3.21 Radioluminescence comparison of the as synthesized gadolinium and
gadolinium/lutetium silicate nanoparticles to commercial Ce:LSO standard.
3.3.6 Cytotoxicity
MTS assays were performed on the cerium doped GSO, GPS, GSAP, and
Gd/LuSO nanoparticles to assess cytotoxicity of the particles towards human embryonic
kidney (HEK) cells (Figure 3.22). HEK cells were chosen to assess cytotoxicity and the
eventuality of kidney toxicity as nanomaterials are commonly processed through the
kidneys for removal from the body.38,39 The particles were incubated with HEK cells for
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72 h. The viability of the untreated cells was set to 100 % in order to calculate the
viability of the cells exposed to the rare earth silicate nanoparticles. The Tukey’s test was
ran on the viability data. The results showed that there was not a statistically significant
difference between the untreated cells and the cells that were exposed to any of rare earth
silicate nanoparticles up to highest tested concentration (3.60×109 particles/mL).

Figure 3.22 MTS assays of human embryonic kidney (HEK) cells incubated with
Gd2SiO5 (GSO), Gd2Si2O7 (GPS), Ce:Gd4.67(SiO4)3O (GSAP), and (GdLu)2SiO5
(GdLuSO) nanoparticles annealed at 1000 °C for 2 h in concentration of
3.60×107 particles/mL, 3.60×108 particles/mL, and 3.60×109 particles/mL.
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3.4 Summary and Conclusions
In summary, a core-shell approach was used to synthesize Ce:Gd4.67(SiO4)3O,
Ce:Gd2SiO5, Ce:Gd2Si2O7, and mixed Ce:Gd/Lu nanophosphors. Cerium doped
gadolinium and mixed gadolinium/lutetium shells were deposited onto silica cores via
urea precipitation. Easily processed SiO2 nanoparticles served as the silicon source to
react with the rare earth shells to produce the crystalline silicate phases after heat
treatment at 1000 °C. It was found that the pH of the reaction mixture has a significant
effect on the layering of the rare earth starting material onto the cores and on maintaining
dispersible particulates. PXRD showed subtle changes to the reaction chemistry or dopant
concentration allotted transformation of orthosilicate, pyrosilicate and apatite phases. The
luminescent properties of these silicate phases under UV and X-ray excitation were
characterized. Luminescence intensity was dependent on silicate phase and dopant
concentration. The gadolinium- orthosilicate, pyrosilicate, and all phases of the mixed
gadolinium/lutetium exhibited intense visible light emission under UV excitation.
Scintillation intensity was systematically increased by careful phase manipulation as well
as lattice host optimization realized through adding lutetium into the matrix. This unique
construction of bright luminescent properties in particles that are sub-100 nm in size,
uniform and spherical in morphology, and dispersible provides promising nanomaterials
for applications in optogenetics.
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CHAPTER FOUR
INVESTIGATION AND ENHANCEMENT OF
SCINTILLATING Eu:RE2O3 (RE = Y, Gd, Lu) NANOSPHERES
4.1 Introduction
Rare earth sesquioxide (RE2O3) functional materials such as single crystals,1,2
ceramics,1,3,4 films,5–8 and crystalline powders9–11 have been extensively studied for their
numerous electrical, magnetic, and optical capabilities. Special attention has been paid to
the unique phosphor properties such as up-conversion luminescence,10,12,13 persistent
luminescence,14,15 storage luminescence,16 and scintillation9,17,18 associated with lanthanide
doped RE2O3 materials due to their high stokes shift, narrow emission spectra, and
minimized photobleaching.19–21 Recently, the focus has shifted to luminescent
nanomaterial for their potential in pharmaceuticals,22 biomedical devices,23 and
bioimaging.24,25 For example, lanthanide doped Gd2O3 particles have been studied for their
unique bimodal use as both luminescent hosts and MRI contrast agents.26,27 Many synthetic
techniques have been reported for the synthesis of RE2O3 particles including
combustion,28,29 co-precipitation,30 sol-gel,7,31 hydrothermal,32,33 reverse emulsion,34,35 and
spray pyrolysis.6,36 It can be quite challenging to control and obtain uniformity of particle
size and morphology when using some of these synthetic techniques. Therefore, an
economic, facile, and scalable urea-based approach was used to produce sub-100 nm
europium doped yttrium oxide (Y2O3), gadolinium oxide (Gd2O3), and lutetium oxide
(Lu2O3) spherical nanoparticles.
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The radioluminescence (RL) of single crystals and ceramics of lanthanide doped
RE2O3 materials have been studied and shown to be efficient scintillators.37 However, their
nanocrystalline counterparts have not received much attention as scintillating materials.
Particularly, there is a lack of radioluminescence data on monodisperse, sub-100 nm
nanoparticles. The property of scintillation at the nanoscale would provide exciting new
pathways for biomedical applications. One such example would be to use nano-scintillators
as light sources in the field optogenetics. Currently, there is a great deal of research being
conducted on engineering opsins for optogenetics that are responsive to red light, because
red light wavelengths scatter less through bodily media as compared to blue light.38,39
Additionally, red absorbing opsins are required to enable RE2O3 scintillators into
optogenetic studies as the cerium produced blue light emission required for traditional
channelrhodopsins is quenched in RE2O3 materials. The Eu:RE2O3 nanoparticles produced
possess emission spectra suitable for the absorption profile of inhibitory opsins, such as
the red-shifted chrimson and cruxhalorhodopsin, Jaws.40,41
Here in the synthesis and radioluminescence of europium doped yttrium oxide,
gadolinium oxide, and lutetium oxide nanospheres is reported. An optical examination of
Eu:RE2O3 ( RE= Y, Gd, Lu) nanoparticles found Eu:Gd2O3 produced the highest intensity
X-ray excited radioluminescence of the three sesquioxides tested. The RL was compared
over different annealing temperatures (800 °C-1200 °C), annealing time lengths (2 h-24 h),
and europium dopant concentrations (0.5 % -16 %). It was found that higher annealing
temperatures and longer annealing times produced higher RL intensity, but also aggregated
the particles therefore diminishing their potential for biological application. Most notably,
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when compared to cerium doped lutetium orthosilicate (Ce:LSO) commercial powder the
2 % Eu:Gd2O3 nanoparticles produced 2X the integrated emission intensity under X-ray
excitation.
In order to increase the flexibility of processing temperature and to increase the
crystallite size, two different techniques were applied to the Eu:RE2O3 nanoparticles in
order to increase the radioluminescence emission intensity. First, an undoped layer was
coated onto the nanoparticles to reduce surface quenching and enhance RL output. The
other method is a novel approach that involves applying a sacrificial, protective glassy
carbon coating used to anneal the particles at higher temperatures while maintaining
dispersity. Although, both techniques showed enhanced RL output the protected coating
method allowed for much higher annealing temperatures and increased crystallinity in the
nanoparticles, which drastically increased the emission intensity. Due to their ease of
synthesis, uniformity, and radioluminescence properties, Eu:RE2O3 nanoparticles would
make excellent candidates as nano-scintillators to continue to move the field of
optogenetics forward.

4.2 Experimental
4.2.1 Reagents
3-(Trimethoxysilyl)propyl methacrylate (MPS) was distilled under a vacuum
environment. Inhibitors from divinyl benzene (DVB) were removed by passing the DVB
through a basic alumina oxide filter. All other reagents were used without further
purification. Urea (CH4N2O,), europium nitrate hexahydrate (Eu(NO3)3·6 H2O, 99.9 %),
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gadolinium nitrate hexahydrate (Gd(NO3)3·6 H2O, 99.9 %), lutetium nitrate hexahydrate
(Lu(NO3)3·6 H2O, 99.99 %), yttrium nitrate hexahydrate (Y(NO3)3·6 H2O).
4.2.2 Preparation of RE2O3 Nanoparticles
The RE2O3 nanoparticles were produced through a urea mediated precipitation
synthesis (Figure 4.1). In a typical synthesis, a 1.2X10-2 M rare earth nitrate solution was
heated and stirred for 15 min at 85 °C. In order to test various dopant concentrations
(0.5 %-16 %) the ratio of the dopant europium nitrate to the major rare earth nitrate
(Gd(NO3)3, Lu(NO3)3, or (Y(NO3)3) was varied accordingly. Next, a 1 M solution of urea
was added to the nitrate solution dropwise. The solution was continued to be stirred and
heated for 2 h. The particles were separated by centrifugation and washed several times
with water and ethanol before then being dried overnight at 85 °C. The dried powder was
annealed in air at 800 °C for 2 h.
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Figure 4.1 Experimental set-up for synthesis of RE2O3 nanoparticles.

4.2.3 RE2O3 Shell Deposition and Heat Treatment
Eu:Y2O3@Y2O3 nanoparticles were prepared by coating the precursor hydrated
europium doped yttrium carbonate nanoparticles via urea precipitation. 0.2 g
Y(NO3)3 · 6H2O and 0.03 g urea were dissolved in 90 mL H2O. Then 0.05 g of the
precursor hydrated Eu:Y(CO3)3 nanoparticles were added to the solution and dispersed via
sonication. The solution was heated to 80 °C for 4 h. The particles were separated by
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centrifugation and washed several times with water and ethanol before then being dried
overnight at 85 °C. The dried powder was annealed in air at 800 °C for 2 h in order to
crystallize the Eu:Y2O3 core and Y2O3 shell.
4.2.4 Carbon Shell Deposition and Heat Treatment
The Eu:Y2O3 nanoparticles were coated in a protective, sacrificial carbon layer
through a method developed by the Foulger group (Figure 2.2).42 Briefly, 30 mg of
Eu:Y2O3 nanoparticles annealed at 600 °C for 2 h were dispersed in a 9:1 (v/v) solution of
methanol and water (12 mL) followed by the addition of MPS (15 µL) and ammonia
hydroxide (115 µL) under reflux conditions for 4 h. The MPS functionalized nanoparticles
were separated and washed in methanol (2x) by centrifugation and dried in an 85 °C oven.
The MPS functionalized Eu: Y2O3 particles (25 mg) were dispersed in acetonitrile (4 mL)
followed by the addition of DVB (25 µL) and azobisisobutyronitrile (1.8 mg). The solution
was purged with nitrogen and heated to 55 °C for 16 h. The pDVB encapsulated Eu: Y2O3
product was separated and washed with methanol (2x) via centrifugation and dried in an
85 °C oven. The pDVB encapsulated Eu: Y2O3 product was purged in a TF 1400 tube
furnace for 20 min and annealed at 1200 °C for 2 h under a constant flow of nitrogen.
Amorphous carbon was combusted by introducing air at 800 °C for 1 h. SEM images of
the major synthetic stages are shown in Figure 4.3.
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Figure 4.2 Scheme of the sacrificial carbon coated RE2O3 annealing process.

Figure 4.3 SEM images of sacrificial carbon coating process (a.) 2 % Eu:Y2O3
nanoparticles annealed at 600 °C for 2 h, (b.) 2 % Eu:Y2O3 nanoparticles with pDvB
coating, (c.) 2 % Eu:Y2O3 with pDvB coating annealed at 1200 °C for 2 h in N2, and (d.)
2 % Eu:Y2O3 after annealing at 800 °C for 1 h in air to burn off carbon coating. The scale
bar is 200 nm in all images.
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2.2.5 Sample Characterization
Crystal phase, crystallinity, and crystallite size were monitored from powder x-ray
diffraction (PXRD). The PXRD data was collected by a Rigaku Ultima IV equipped with
CuKα radiation (λ = 1.5406). The diffraction data was collected with a scan speed of 1 °/min
over a 2 θ range of 5 ° to 65 ° in 0.2 ° increments.
A Hitachi S4800 field emission scanning electron microscope (SEM) with an
accelerating voltage of 10 kV was used to assess and image the shape and size of the RE2O3
particles. The particles were deposited onto carbon tape dropwise after being sonicated in
water. The samples were sputter coated with platinum for 2 min before imaging.
Fourier-transform infrared spectroscopy (FTIR) was used to collect infrared spectra
on the RE2O3 nanoparticle powders using a Nicolet Magna IR Spectrometer 550. The
samples to be analyzed were ground with potassium bromide (KBr) and pressed into
pellets. The data was collected in the frequency range of 400–4000 cm−1 with a resolution
of 4 cm−1.
The TGA experiment was performed on an SDT Q600 (V20.9 Build 20)
instrument. Approximately 5 mg of the sample was put into an alumina crucible and was
heated in a nitrogen atmosphere at 10 °C/ min from 20 °C to 800 °C.
The as prepared RE2O3 particles were dispersed in films of PDMS before their
luminescent properties were measured. A Jobin Yvon Fluorolog 3-222 spectrometer with
double grating configuration and xenon lamp source was used to collect
photoluminescence measurements of the samples. The spectra were collected with 2 mm
slit width and scan speed of 0.1 nm/sec. Radioluminescence spectra of the RE2O3 particles
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were collected by exposing the sample to tungsten sourced X-ray radiation. The mini X-ray
tube (Amptek Inc.) was operated at a voltage of 50 kV and current of 79 μA for all collected
spectra. The visible light emitted by the samples were collected with a fiber bundle (Oriel)
coupled to a MicroHR (Horiba Jobin Yvon) monochromator and a cooled CCD detector
(Synapse, Horiba Jobin Yvon) The exposure time was varied from 1 s – 5 s based on the
relative luminescence.
4.2.6 MTS Assay
The Human Embryonic Kidney (HEK) cells were obtained from ATCC and
cultured at 37 °C in a humidified atmosphere of 95 % air / 5 % CO2. The HEK cells were
cultured in Dulbecco’s modified Eagle’s media (DMEM) containing 10 % FBS and 5 %
L-glutamine. The cells were plated for 24 h at 3,500 cells per well in a 96 cell well plate.
The cells were separately incubated with the Y2O3, Lu2O3, and Gd2O3 particles in
concentrations of 1 μg/mL, 10 μg/mL, and 100 μg/mL. After 72 h of incubation with the
RE2O3 particles the cells’ viability was measured using MTS assay (CellTiter 96 AQueous
One Solution Cell Proliferation Assay, Promega) following the manufacturer’s
instructions. The particles and media were removed from the cells and replaced with
200 μL of DMEM media and 40 μL of the MTS tetrazolium reagent. The MTS solution
was incubated with the cells for 3 h. The absorbance was measured using a plate reader at
OD = 490 nm. The data was collected in triplicate.
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4.3 Results and Discussion
4.3.1 Phase Identification and Morphology of RE2O3 Nanospheres
The RE2O3 particles were synthesized via an urea based precipitation method as
previously described. Fourier transform infrared spectroscopy (FTIR) was used to analyze
the evolution of the precursor nanoparticles after precipitation until formation of the
crystalline RE2O3 phase (Figure 4.4). FTIR measurements were collected at various
temperature points (85 °C – 800 °C). All spectra showed a broad absorption band over the
range of 3000-3700 cm-1 corresponding to OH stretching. The OH stretching band
decreased dramatically as the nanoparticles were heated at higher temperatures and is
barely visible in the sample annealed at 800 °C. The absorption band from the OH bending
frequency is hardly noticeable at 1630 cm-1 as a shoulder on the CO32- asymmetric
stretching band.43 The presence of CO32- ions in the precursor nanospheres is also
confirmed by the peaks at 1510 cm-1 and 1402 cm-1 which correspond to the ν3 asymmetric
and symmetric stretching of the CO32- group. The ν2 out of plane stretching mode from the
CO32- ion at 844 cm-1 and the ν1 stretching mode peak at 1080 cm-1 are visible for the
powders annealed up to 400 °C.44 The FTIR spectra of the samples annealed at 600 °C and
800 °C both contain a peak at approximately 560 cm-1 characteristic of the vibration from
the Y-O bonds. From the FTIR results it was concluded that the precursor precipitated
particles were hydrated RE2(CO3)3 species. The trace amount of H2O present in the samples
annealed at higher temperatures can be attributed to water absorption from the air and
preparation conditions.45 Similarly, the CO32- peaks are likely caused from annealing in
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air, as chelating and bridging carbonates are some of the most common species formed
during CO2 absorption.46,47

Figure 4.4 FTIR spectra of 2 % Eu:Y2O3 nanoparticle powder annealed at indicated
temperatures.
Thermogravimetric analysis (TGA) measurements were conducted on the Eu:Y2O3
precursor nanoparticles after they were dried overnight at 85 °C to further characterize the
initial amorphous nanoparticles (Figure 4.5). The TGA results showed that the synthesized
particles had a weight loss of roughly 37 weight% over a temperature range of
50 °C-700 °C. There was no further change in weight above 700 °C. The weight loss can
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be attributed to the loss of water molecules and the removal of carbon in the conversion of
carbonate to oxide. This result substantiated the hypothesis of the precursor material being
composed of hydrated rare earth carbonate nanoparticles.

Figure 4.5 TGA curve of 2 % Eu:Y2O3 precursor nanoparticle powder in nitrogen
atmosphere heated from 20 °C to 800 °C at 10 °C/min.
The RE2O3 particles were synthesized via a urea based precipitation method as
previously described. Figure 4.6 shows the powder X-ray diffraction (PXRD) patterns of
the Eu:Gd2O3, Eu:Lu2O3, and Eu:Y2O3 nanospheres annealed at 800 °C for 2 h. All three
RE2O3 products crystallized in the cubic Ia3� phase after being annealed at 800 °C for 2 h.

121

Figure 4.6 PXRD spectra of Gd2O3, Y2O3, and Lu2O3 calculated from published single
crystal data in black48 to compared to the as synthesized nano- Eu:Gd2O3, Eu:Lu2O3, and
Eu:Y2O3 powders annealed at 800 °C for 2 h.
Scanning electron microscopy (SEM) was used to analyze the shape and size of the
RE2O3 nanoparticles. The reaction time and urea concentration played a significant role in
the morphology of the particles. Multiple sizes of the nanospheres were formed when the
concentration of urea was below 0.5 M (Figure 4.7-a). When the reaction was continued
over longer time periods ( > 4 h), the nanoparticles assembled into large disks that
interlocked with one another to form flower-like microarchitectures (Figure 4.7-b).
Smaller (60 nm), less well-formed nanoparticles were produced when the concentration of
urea was above 1 M (Figure 4.7-c). Careful attention was paid to the reaction paraments
to obtain uniform, spherical nanoparticles with an average diameter of 90 nm of all three

122

RE2O3 products, Eu:Y2O3 (Figure 4.7-d) , Eu:Lu2O3 (Figure 4.7-e) , Eu:Gd2O3 (Figure
4.7-f).

Figure 4.7 SEM images of the Eu:Y2O3 particles annealed at 800 °C and synthesized using
(a.) 0.5 M urea and 2 h reaction time, (b.) 1 M urea and 24 h reaction time, and (c.) 2 M
urea and 2 h reaction time. SEM image of (d.) Eu:Y2O3, (e.) Eu:Lu2O3, and (f.) Eu:Gd2O3
nanoparticles produced under 1 M urea and 2 h reaction conditions and then annealed at
800 °C for 2 h. The white scale bar measures 500 nm in each image.
4.3.2 Annealing Conditions
Comparable to the FTIR data, PXRD measurements were taken after annealing the
powders in 100 °C increments to track the progress and crystallization of the RE2O3
nanoparticles (Figure 4.8). The particles were amorphous after drying overnight at 85 °C.
The particles remained predominately amorphous, as shown in the first PXRD spectra in
Figure 4.8 as one broad, low intensity peak until 500 °C. The PXRD of the products
annealed at 500 °C exhibit the first signs of crystallization of the RE2O3 cubic phase
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however, with some remaining amorphous character. The peaks in the PXRD spectra of
the nanoparticles annealed at all tested temperatures above 500 °C are consistent with the
cubic Ia3� RE2O3 phase.48 It is important to understand that the nanoparticles themselves

are not completely crystalline RE2O3 but are a mixture of crystalline phase and amorphous

metal oxide. Since the emission is far brighter from larger crystals, it was important to
maximize the size of the single crystallites within the nanoparticles while still maintaining
the sub-100 nm monodispersed nanoparticle morphology. The size of the crystallites within
the nanospheres were calculated at each annealing stage from the broadening in the PXRD
using the Scherrer equation: t = K λ/(β cos θ), where λ is the X-ray wavelength, K is
dimensionless shape factor, β is the broadening at half the maximum intensity of the line
sited at θ angle. There was a rapid crystallite size increase from 3.1 nm at 500 °C to 9.9 nm
at 600 °C, followed by a gradual change of 6 nm total from 600 °C to 900 °C. The largest
change in crystallite size was a difference of 11.7 nm between the particles annealed at
1100 °C compared to those annealed at 1200 °C. The crystallite size of the RE2O3
nanoparticles increased overall from 3.8 nm to 40.5 nm as the annealing temperature was
increased from 500 °C to 1200 °C. There was noticeable change in morphology when the
particles were annealed at higher temperature. The particles begin to aggregate and sinter
together to form larger species when annealed above 800 °C (Figure 4.9). As 800 °C was
found to be the ideal temperature to produce crystalline and monodispersed RE2O3
nanoparticles the temperature was held at 800 °C and the length of time of annealing was
varied (2 h – 24 h). It was found that increasing the annealing time had a less significant
effect on the crystallite size as compared to increasing the annealing temperature. The
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crystallite size increased by only 6 nm on average when annealed at 800 °C for 24 h
compared to the typical synthetic procedure of annealing at 800 °C for 2 h (Figure 4.10).
The particles also showed signs of sintering when annealed for prolonged time periods
(Figure 4.11).

Figure 4.8 PXRD spectra of 2 % Eu:Y2O3 nanoparticle powder annealed at given
temperatures for 2 h with Scherrer calculated crystallite sizes.
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Figure 4.9 SEM images of Eu:Y2O3 nanoparticles annealed at (a.) 900 °C, (b.) 1000 °C,
(c.) 1100 °C, (d.) 1200 °C for 2 h. The white scale bar measures 200 nm in each image.
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Figure 4.10 PXRD of Eu:Y2O3 nanoparticles annealed at 800 °C for the indicated time
lengths.
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Figure 4.11 SEM images of Eu:Y2O3 nanoparticles annealed at 800 °C for (a.) 2 h, (b.)
8 h, (c.) 16 h, and (d.) 24 h. The white scale bar measures 500 nm in each image.
4.3.3 Photoluminescence
Photoluminescence (PL) and photoluminescence excitation (PLE) measurements
were conducted on the Eu:RE2O3 nanoparticles. The photoluminescence excitation spectra
of the Eu:Y2O3 nanoparticles showed a broad band centered around 255 nm which
corresponds to the charge transfer from O2- (2p) to Eu3+ (4f) (Figure 4.12). The other
visible excitation bands are due to 4f to 4f Eu3+ transitions from the 7F0 ground state to
various excited states. All photoluminescence spectra contained peaks consistent with
previously reported europium doped rare earth oxide emission profiles.7,32,37 The PL
spectra showed multiple transitions from the excited 5D0 state to the 7FJ levels. The most
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intense peak was at 611 nm for each RE2O3 sample and is due to the hypersensitive
transition to the 7F2 energy level.49

Figure 4.12 PLE ( λem = 611 nm) and PL (λex = 255 nm) spectra of 2 % Eu:Y2O3
nanoparticles annealed at 800 °C for 2 h.
The PL and PLE spectra were similar for all of the Eu:RE2O3 nanoparticles and
only notably different in emission intensity (Figure 4.13). To compare the emission
intensity between the Eu:RE2O3 particles, the dopant concentrations was held at 2 mol%
europium and the 611 nm emission band was monitored. The Eu:Gd2O3 nanoparticles
exhibited the highest emission intensity followed closely by the Eu:Y2O3 sample. The
emission intensity from Eu:Lu2O3 was roughly half the intensity of Eu:Y2O3 and a third of
the intensity of Eu:Gd2O3.

PL was measured for various dopant concentrations

(0.5 % - 16 %) and annealing temperatures (800 °C – 1200 °C). PL emission intensity
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increased until reaching the highest intensity at 2 %, 8 %, and 4 %, for Eu:Gd2O3,
Eu:Lu2O3, and Eu:Y2O3 respectively (Figure 4.14). The intensity of the PL emission
remained relatively consistent for Eu:Gd2O3 and Eu:Y2O3 regardless of annealing
temperature (Figure 4.15). However, for the Eu:Lu2O3 particles, the sample annealed at
1200 °C produced a significantly more intense emission compared to Eu:Lu2O3 samples
annealed at lower temperatures consistent with the increased formation of larger size
crystallites within the nanoparticles.

Figure 4.13 Relative comparison of the 2 % Eu:Gd2O3 (λex =261 nm), 2 % Eu:Lu2O3 (λex
=257 nm), and 2 % Eu:Y2O3 (λex =255 nm) nanoparticles annealed at 800 °C for 2 h.
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Figure 4.14 Comparative photoluminescence emission intensities of Eu:Y2O3(λex =
257 nm), Eu:Gd2O3 (λex = 261 nm), and Eu:Lu2O3(λex = 257 nm) nanoparticles with varied
europium dopant concentration annealed at 800 °C for 2 h.
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Figure 4.15 Comparative photoluminescence emission intensities of Eu:Y2O3(λex =
257 nm), Eu:Gd2O3 (λex = 261 nm), and Eu:Lu2O3(λex = 257 nm) nanoparticles annealed at
the indicated temperatures (800 °C – 1200 °C) for 2 h.
4.3.4 Radioluminescence
X-ray excited radioluminescence (RL) emission measurements were recorded for
the Eu:RE2O3 nanoparticles. The RL spectra matches the 4f-4f Eu3+ transitions for all three
Eu:RE2O3 nanoparticle types. The measured radioluminescence spectra were comparable
to the photoluminescence spectra in all cases, albeit with some reduction in spectral
resolution. The most intense peak again for all three Eu:RE2O3 nanoparticles was seen at
611 nm due to the 5D0 to 7F2 transition. The Eu:Gd2O3 sample produced roughly double
the emission intensity at 611 nm compared to Eu:Y2O3 and had 3.5X more intense emission
compared to the Eu:Lu2O3 sample (Figure 4.16).
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Figure 2.16 RL spectra 2 % Eu:RE2O3 (RE = Gd, Lu, Y) nanoparticles annealed at 800 °C
for 2 h. Samples were irradiated with tungsten sourced X-rays operated at a voltage of
50 kV and current of 79 μA.
Radioluminescence of each Eu:RE2O3 product was measured over various
europium dopant concentrations (0.5 % -16 %) in order to find the optimized concentration.
All Eu:RE2O3 samples showed diminished RL emission intensity when the highest dopant
concentration (16 %) was tested. A dopant concentration of 2 % produced the highest RL
emission intensity for Eu:Gd2O3 and Eu:Lu2O3 particles (Figure 4.17). Eu:Y2O3 exhibited
intensities in the same relative range of each other for dopant concentrations 1 % - 8 %,
with only a gradual increase of intensity with increased dopant concentration (Figure
4.17).
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Figure 4.17 Comparative radioluminescence emission intensities of Eu:Y2O3, Eu:Gd2O3,
and Eu:Lu2O3 nanoparticles with varied europium dopant concentration annealed at 800 °C
for 2 h. Samples were irradiated with tungsten sourced X-rays operated at a voltage of
50 kV and current of 79 μA.
The Eu:RE2O3 nanoparticles were measured under the same conditions as cerium
doped lutetium orthosilicate (Ce:LSO) standard powder purchased from Phosphor
Technologies as a means to compare scintillation emission intensities (Figure 4.18).
Ce:LSO is a commercial scintillator that was used as a standard of comparison for
radioluminescence emission. All three Eu:RE2O3 nanoparticles had more intense emission
peaks under X-ray excitation compared to the Ce:LSO standard. However, the Ce:LSO
standard had an integrated emission intensity slightly higher than that of the Eu:Lu2O3 and
Eu:Y2O3 nanoparticles. However, the Eu:Gd2O3 nanoparticles had an integrated emission
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intensity more than 2X that of the Ce:LSO standard even though the Ce:LSO powder
contains much larger particle and crystallite sizes.

Figure 4.18 RL comparative spectra of commercial Ce:LSO standard purchased from
Phosphor Tecnhologies to 2 % Eu:RE2O3 (RE= Gd, Lu, Y) nanoparticles annealed at
800 °C for 2 h. Samples were irradiated with tungsten sourced X-rays operated at a voltage
of 50 kV and current of 79 μA.
4.3.5 Effects of Annealing Conditions on Radioluminescence
Radioluminescence data was also collected on the Eu:RE2O3 particles annealed at
varying temperatures and time lengths to assess the effect annealing conditions had on RL
emission intensity. All tested Eu:RE2O3 samples showed enhanced RL intensity with
increased annealing temperature. The increase in intensity was likely a result of increased
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crystallinity and crystallite size achieved at the higher annealing temperatures. The effect
of annealing temperature on RL intensity was more pronounced in the Eu:Y2O3 and
Eu:Lu2O3 samples as compared to the Eu:Gd2O3 sample (Figure 4.19). RL emission from
Eu:Y2O3 and Eu:Lu2O3 showed a drastic increase in intensity when annealed at 1200 °C
compared to lower annealing temperatures. Although, RL intensity increased with
increasing annealing temperature the nanoparticles began to aggregate at 900 °C and were
severely sintered when annealed above 1000 °C. The Eu:Y2O3 samples annealed at 800 °C
for extended time periods showed only a slight increase in RL intensity with increased
annealing time (Figure 4.20). This RL result correlates with the PXRD data showing only
slightly increased crystallite sizes when applying longer annealing times to the nanopowders.
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Figure 4.19 Comparative radioluminescence emission intensities of Eu:Y2O3, Eu:Gd2O3,
and Eu:Lu2O3 nanoparticles annealed at the indicated temperatures (800 °C – 1200 °C) for
2 h. Samples were irradiated with tungsten sourced X-rays operated at a voltage of 50 kV
and current of 79 μA.
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Figure 4.20 RL emission spectra of 2 % Eu:Y2O3 nanoparticles annealed at 800 °C for the
indicated time lengths (2 h – 24 h). Samples were irradiated with tungsten sourced X-rays
operated at a voltage of 50 kV and current of 79 μA.
4.3.6 Enhancing Radioluminescence
Two different techniques shown to enhance optical properties of luminescent
materials were applied to the Eu:Y2O3 nanoparticles as means to test the feasibility of
increasing the radioluminescence emission output. The first emission enhancing technique
tested was to apply an undoped, passive layer onto the nanoparticles to reduce surface
quenching sites. The advantages and synthesis of coating an undoped, passive layer onto
optical materials have been recorded extensively in the literature.50–52 The protective
undoped layer can help to reduce surface quenching and enhance radioluminescence. In
order to test this property in the RE2O3 system, a thin layer of Y2O3 was coated onto the
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2 % Eu:Y2O3 nanoparticles by urea precipitation and annealed at 800 °C. The particles
remained uniform and spherical after the coating and annealing at 800 °C for 2 h (Figure
4.21). The particles coated with a protective shell Eu:Y2O3@Y2O3 showed enhanced RL
emission compared to the uncoated nanoparticles Eu:Y2O3 annealed at the same
temperature (Figure 4.22).

Figure 4.21 SEM of (a) precursor hydrated yttrium carbonate particles dried at 85 °C and
(b) Eu:Y2O3@Y2O3 nanoparticles annealed at 800 °C for 2 h. The white scale bar measures
200 nm in each image.
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Figure 4.22 RL comparative spectra of Eu:Y2O3 nanoparticles annealed at 800 °C for 2 h
and Eu:Y2O3@Y2O3 nanoparticles annealed at 1200 °C for 2 h in N2 and then at 800 °C
for 2 h in air.
The second technique tested to increase radioluminescence intensity of the Eu:Y2O3
nanoparticles was developed by the Foulger group and then adapted for the RE2O3
system.42 The technique involves creating a sacrificial, protective barrier between the
nanoparticles in order to prevent sintering while annealing at higher temperatures. The
protective barrier an amorphous carbon coating produced by the radical polymerization of
poly(divinylbenzene) (pDvB) from the surface of the nanoparticles followed by annealing
in an inert atmosphere to induce the carbonization of the polymer coating. After annealing
the oxide particles within the carbon shell in an inert atmosphere, the carbonized coating
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can then be removed from the nanoparticles by annealing the material in air at a lower
temperature to burn off the carbon. A temperature of 800 °C was selected to remove carbon,
because it does so cleanly and does not induce further sintering of the Eu:Y2O3
nanoparticles. The final nanoparticles retained their shape and size after being annealed at
1200 °C for 2 h in the protected carbon shell (Figure 4.23). It should be recalled that the
Eu:Y2O3 particles without the carbon coated became sintered when annealed at 1200 °C.
The carbon coated Eu:Y2O3 nanoparticles annealed at 1200 °C had an increased average
crystallite size of 15.6 nm compared to 11.5 nm of the Eu:Y2O3 particles annealed at 800 °C
(Figure 4.24). The carbon coating restricts the particles from sintering together and
creating large particles but allows the crystallites to increase in size. The Eu:Y2O3
nanoparticles protected by carbon while being annealed at 1200 °C for 2 h showed a
significant increase in radioluminescence intensity. The carbon protected Eu:Y2O3
nanoparticles annealed at 1200 °C had an emission intensity 3X the emission intensity of
the unmodified Eu:Y2O3 nanoparticles annealed at 800 °C (Figure 4.25).
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Figure 4.23 (a.) SEM of Eu:Y2O3 particles annealed at 600 °C for 2 h and (b.) Eu:Y2O3@C
annealed at 1200 °C for 2 h then annealed in air at 800 °C for 2 h. The white scale bar
measures 200 nm in each image.

Figure 4.24 PXRD of Eu:Y2O3 nanoparticles annealed at 800 °C for 2 h and carbon coated
Eu:Y2O3 nanoparticles annealed in N2 at 1200 °C for 2 h and then in air at 800 °C for 1 h.
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Figure 4.25 RL comparative spectra of Eu:Y2O3 nanoparticles annealed at 800 °C for 2 h
and Eu:Y2O3@C annealed at 1200 °C for 2 h in N2 and then at 800 °C for 2 h in air.
4.3.7 Cytotoxicity
MTS assays were performed on all three Eu:RE2O3 nanoparticles to assess
cytotoxicity of the particles towards human cells (Figure 4.26). The particles were
incubated with human embryonic kidney (HEK) cells for 72 h. The viability of the
untreated cells was set to 100 % in order to calculate the viability of the cells exposed to
the Eu:RE2O3 nanoparticles. The Tukey’s test was ran on the viability data. The results
showed that there was not a statistically significant difference between the untreated cells
and the cells that were exposed to any of Eu:RE2O3 nanoparticles up to highest tested
concentration (100 μg/mL).
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Figure 4.26 MTS assays of human embryonic kidney (HEK) cells incubated with RE2O3
(RE = Gd, Lu, Y) nanoparticles annealed at 800 °C for 2 h in concentration of 1 μg/mL,
10 μg/mL, and 100 μg/mL.

4.4 Summary and Conclusions
Europium doped rare earth oxide (RE = Gd, Lu, Y) scintillators with nanosphere
structure were synthesized via a simple urea precipitation with subsequent calcination for
use in biomedical applications. The reaction conditions were optimized in order to produce
the Eu:RE2O3 products as monodispersed, uniform, sub 100 nm spheres. The luminescent
properties under both UV and X-ray excitation of the particles were analyzed. The
Eu:Gd2O3 nanoparticles produced the most intense emission in both cases compared to the
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other Eu:RE2O3 products. The dopant concentration and annealing temperatures were
varied to optimize emission intensity. A 2 mol% europium concentration produced the
most intense emission in the Eu:Gd2O3 nanoparticles under both excitation sources. PL
emission intensity was not greatly affected by the annealing temperature for any of the
Eu:RE2O3 products. However, there was a correlation between annealing conditions and
RL emission. RL emission intensity increased with increased annealing temperature and
annealing time for all Eu:RE2O3 samples. Unfortunately, the material was found to
aggregate at higher annealing temperatures and times and therefore forfeited their
dispersity. The 2 % Eu:Gd2O3 nanoparticles produced 2X greater integrated intensity when
compared to a Ce:LSO commercial standard. Two techniques proposed to enhance optical
properties of luminescent materials were tested on the Eu:Y2O3 nanoparticles. The first
technique increased RL output and involved the reduction of surface quenching by
application of a thin undoped layer of Y2O3 onto the nanoparticles. The second technique
included annealing the Eu:Y2O3 nanoparticles at 1200 °C while enclosed in a protective
carbon coating and increased RL emission intensity by 3X compared to the Eu:Y2O3
nanoparticles annealed at 800 °C for 2 h. The Eu:RE2O3 nanoparticles are particularly
exciting options for optogenetics and other biomedical applications, because they can be
readily made as uniform and monodisperse nanospheres as well as produce efficient
scintillation.
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CHAPTER FIVE
SYNTHESIS STRATEGIES FOR THE PRODUCTION OF SUB
100 nm Tb:Y2O2S PARTICLES
5.1 Introduction
The field of optogenetics has been under explosive growth since its establishment
15 years ago.1–3 Scientists have been finding and creating variants of opsins, primarily
variants of the well-studied channelrhodopsin. The variants possess modified properties
such as changes to channel specificity and activation wavelength. The recent focus has
been on creating opsins with red shifted absorbance as the blue light used to active
channelrhodopsin is heavily absorbed and scattered in bodily tissue.4 VChR1, a variant of
channelrhodopsin, enables the same cation-conducting action of channelrhodopsin
however under green light activation.5 Additional opsin variants have been found to be
active to green light and have the ability to facilitate the activation or inhibition of various
neural functions. For example, eNpHR, a natronomonas halorhodopsin, can serve as a
chloride pump under green light to inhibit neural activity.6 As these new opsins come to
light a need for green emitting nano-scintillators are required to serve as non-invasive light
sources for continued optogenetic studies.
Rare earth oxysulfide (REOS) phosphors are useful for numerous technologies
such as thermographics,7 display devices,8 radiation detection,9 and medical diagnosis.10,11
Additionally, REOS have been shown to be efficient scintillators due in part to their
radiation hardness, high X-ray absorption, and conversion efficiency.12 Yttrium oxysulfide
(YOS), Y2O2S, is an effective host for terbium doping and has been reported to produce
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the desired green light emission under X-ray excitation.13 A number of YOS materials
including ceramics, films, and powders have been reported. YOS powders have been
produced in a series of different morphologies including more exotic structures such as
flower14 and worm-like15. However, for YOS to be suitable for the desired biomedical
application, beyond being a bright scintillator, the particles must be uniform, dispersible
spheres that have a diameter less than 100 nm.
The intent of chapter 5 is to report the comparison of different synthetic methods
and their effect on the morphology of Tb:Y2O2S nanoparticles. Of the three methods used
to synthesize the Y2O2S phase, the co-precipitation synthesis produced particles that meet
the requirements of uniformity, dispersity, and sub-100 nm size to be tested for noninvasive
optogenetics. Luminescence measurements of the Tb:Y2O2S nanoparticles under both UV
and X-ray excitation were collected. The nano-scintillators exhibited the desired bright
green emission with an integrated intensity greater than that of a commercial cerium doped
lutetium orthosilicate (Ce:LSO) standard. The Tb:Y2O2S nanoparticles presented herein
offer the unique potential to provide green light to opsins without surgical implantation.

5.2 Experimental
5.2.1 Materials
All materials were obtained from commercial suppliers and used without further
purification. Urea (CH4N2O,) terbium nitrate (Tb(NO3)3 ·6H2O), yttrium nitrate
hexahydrate (Y(NO3)3·6H2O, 99.9 %), sulfur powder, sodium carbonate (Na2CO3),
thiourea.
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5.2.2 Characterization
Crystal phase, crystallinity, and crystallite size were monitored from powder x-ray
diffraction (PXRD). The PXRD data was collected by a Rigaku Ultima IV equipped with
CuKα radiation (λ = 1.5406 nm). The diffraction data was collected with a scan speed of
1 °/min over a 2θ range of 5 ° to 65 ° in 0.2 ° increments.
A Hitachi S4800 field emission scanning electron microscope (SEM) with an
accelerating voltage of 10 kV was used to assess and image the shape and size of the REOS
particles. The particles were deposited onto carbon tape dropwise after being sonicated in
water. The samples were sputter coated with platinum for 2 min before imaging.
The as prepared particles were dispersed in films of PDMS before their luminescent
properties were measured. A Jobin Yvon Fluorolog 3-222 spectrometer with double grating
configuration and xenon lamp source was used to collect photoluminescence
measurements of the samples. The spectra were collected with 2 mm slit width and scan
speed of 0.1 nm/sec. Radioluminescence spectra of the Tb:Y2O3 and Tb:Y2O2S particles
were collected by exposing the sample to tungsten sourced X-ray radiation. The mini X-ray
tube (Amptek Inc.) was operated at a voltage of 50 kV and current of 79 μA for all collected
spectra. The visible light emitted by the samples were collected with a fiber bundle (Oriel)
coupled to a MicroHR (Horiba Jobin Yvon) monochromator and a cooled CCD detector
(Synapse, Horiba Jobin Yvon) The exposure time was varied from 1 s – 5 s based on the
relative luminescence.
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5.2.3 Tb:Y2O3 Synthesis
Tb:Y2O3 nanoparticles were produced through the urea mediated precipitation
synthesis described in Chapter 4. Briefly, a 1.2X10-2 M rare earth nitrate solution was
heated and stirred for fifteen minutes at 85 °C. Next, a 1 M solution of urea was added to
the nitrate solution dropwise. The solution was continued to be stirred and heated for 2 h.
The particles were separated by centrifugation and washed several times with water and
ethanol before then being dried overnight at 85 °C. The dried powder was annealed in air
at 600 °C for 2 h.
5.2.4 Tb:Y2O2S Synthesis
The production of sub-100 nm Tb:Y2O2S nanoparticles was attempted through
three different synthetic methods 1) sulfidation via solid-gas reaction16 2) flux method
synthesis17 and 3) co-precipitation.18 The first synthetic method of sulfidation via solid-gas
reaction effectively involved blowing hot sulfur gas over Tb:Y2O3 nanoparticles. In a
typical synthesis an alumina crucible containing 5 g of sulfur powder was placed down
flow of an alumina crucible containing 0.03 g of synthesized Tb:Y2O3 nanoparticles
(Figure 5.1). The tube furnace was purged with nitrogen and heated to 900 °C for 3 h while
under the continuous flow of nitrogen.
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Figure 5.1 Schematic of sulfidation of Tb:Y2O3 to Tb:Y2O2S in a tube furnace heated to
900 °C for 3 h.
The second synthetic technique of the flux method was set-up in a similar way, but
with the addition of a flux agent. 0.352 g Na2CO3 powder was ground with 0.015 g of the
synthesized Tb:Y2O3 nanoparticles and placed within the same alumina crucible. 0.319 g
sulfur was placed in an alumina crucible up flow from the Na2CO3/Tb:Y2O3 mixture. The
tube furnace was heated to 900 °C for 3 h while under the continuous flow of nitrogen gas.
The last method tested was a urea assisted co-precipitation. 90 mL H2O containing
0.225 g Y(NO3)3 · 6H2O and 54 μL 0.224 M Tb(NO3)3 was heated in an oil bath to 85 °C
for 15 min. 3 g thiourea was added to the solution and continued to heat and stir for an
additional 15 min. Then 3 g urea was added to the solution. The solution was stirred for
2 h and became slightly opaque. The particles were separated with centrifugation and
washed several times with water. The powder was dried in an oven at 85 °C overnight. The
dried powder was then annealed in the tube furnace under the flow of nitrogen at 900 °C
for 3 h.
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5.3 Results and Discussion
5.3.1 Comparison of Synthesis Strategies
Terbium doped Y2O2S nanoparticles were targeted to be used as nano-scintillators
due to their reported bright bulk radioluminescence. The morphology of the final product
was highly dependent on the synthetic route chosen. The first synthetic method attempted
was based off sulfidation techniques reported in the literature. This technique involves
annealing precursor nanoparticles such as rare earth- carbonate, hydroxide, or oxide
nanoparticles with sulfur powder.19,20 The solid-gas reaction was adapted in effort to
produce sub-100 nm Y2O2S. As the size is largely dependent on the precursor nanoparticle,
it was hypothesized that sub-100 nm Y2O2S particles could be produced through the
reaction of 90 nm Y2O3 nanoparticles with gaseous sulfur at sufficiently high temperatures.

Figure 5.2 PXRD of Y2O2(SO4) particles annealed at 900 °C for 3 h.
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In order to test this theory freshly synthesized Y2O3 nanoparticles and sulfur
powder were annealed together in a tube furnace. The reaction takes place at temperatures
above sulfur’s boiling point and under the flow of an inert gas. This allows gaseous sulfur
to interact with the precursor Y2O3 nanoparticles. Additionally, the reaction needs to be
done in an inert atmosphere as the product would readily oxidize to the yttrium oxysulfate
(Y2O2SO4) phase during annealing in the presence oxygen (Figure 5.2). The Y2O2S
product synthesized through this sulfidation method had observed necking between the
particles (Figure 5.3). The necking between the particles is believed to be due to excess
sulfur forming bonds between the particles as necking is not seen in Y2O3 particles
annealed at the same temperature absent of sulfur. Sulfur was used in excess, because it
was found too little sulfur would lead to incomplete conversion of the precursor Y2O3 phase
to the final Y2O2S phase. The high surface area of the Y2O3 nanoparticles also promotes
the aggregation of the particles. The solid-gas reaction technique however useful for
synthesis of larger sized Y2O2S material may not be suitable for sub-100 nm particles. The
nano-scintillators proposed for optogenetics are required to be dispersible in order to get
through the body to the desired brain area and therefore the Y2O2S nanoparticles produced
through this method would not be ideal.
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Figure 5.3 SEM of Y2O2S nanoparticles synthesized through solid-gas reaction sulfidation
at 900 °C for 3 h.
In order to obtain Tb:Y2O2S particles suitable for use in optogenetics a flux agent
was added to promote the sulfidation reaction using less sulfur. It was believed that the
unwanted necking between particles was caused by excess sulfur, however reducing the
concentration of sulfur in the reaction resulted in incomplete conversion to the Y2O2S
phase. The flux method was then attempted to produce phase pure Y2O2S product without
excess sulfur. A flux is material that possess a lower melting point than the temperature of
the reaction, dissolves the reactant(s), and allows for transport of the material without
incorporating into the product.21 The flux method was also carried out in the tube furnace
under the flow of nitrogen with sulfur and Y2O3 nanoparticles, but with the addition of
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NaCO3. The sulfur required for the conversion was over 15X less than the amount needed
without Na2CO3. Figure 5.4 shows PXRD data comparing products from sulfidation
reactions with and without the NaCO3 flux. When 0.319 g S was used no conversion to the
desired Y2O2S phase occurred until the NaCO3 flux was added and then phase pure Y2O2S
product was obtained. There was a distinct change in the morphology of the particles
however when the Na2CO3 was used and the product formed as much larger hexagonal
plates (Figure 5.4). The Y2O2S products achieved from the solid-gas and flux methods
formed the desired phase however did not have the ideal morphology to be used in
optogenetic application.

Figure 5.4 PXRD of products from solid-gas sulfidation and flux method (left) and SEM
image of Y2O2S particles synthesized from flux method with Na2CO3 (right).
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The last synthetic method tested was a co-precipitation using thiourea as the sulfur
source and yttrium nitrate as the yttrium source. This co-precipitation technique was
inspired by the previous success of the Y2O3 nanoparticles. The Y2O3 nanoparticles can be
readily and reproducibility synthesized through a urea assisted precipitation method. Due
to this they were used as precursors for the solid-gas and flux method syntheses. The
precipitation method was then modified to produce Y2O2S nanoparticles. The precipitated
precursor nanoparticles were uniform and spherical with an average diameter of 115 nm.
After annealing the precursor particles at 900 °C for 2 h the Y2O2S phase was formed while
retaining the desired dispersible morphology (Figure 5.5). The particles densified during
annealing resulting in a reduced average diameter of 90 nm.

165

Figure 5.5 SEM of a) precipitated precursor nanoparticles after drying at 85 °C and b) the
final product Tb:Y2O2S nanoparticles annealed at 900 °C for 3 h. C) PXRD of Y2O2S
nanoparticle synthesized through coprecipitation annealed at 900 °C for 3 h.
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5.3.2 Photoluminescence (PL)

Figure 5.6 Photoluminescence excitation (PLE) (λex = 545 nm) and photoluminescence
emission (PL) (λem = 280 nm) of 2 % Tb:Y2O2S nanoparticles.
After identifying a synthetic method to reliably produce Tb:Y2O2S nanoparticles,
photoluminescence measurements were taken as a preliminary assessment of their optical
properties. The Y2O2S phase is important because it is a good host for terbium doping
which allows for bright green emission. As mentioned, a number of important opsin
variants are responsive to green light. The excitation spectra of the Tb:Y2O2S nanoparticles
consists of two broad bands with peaks at 260 nm and 285 nm (Figure 5.6). The absorption
bands are attributed to the Tb3+ 4f to 5d transition.22 The emission profile of the Tb:Y2O2S
nanoparticles consists of two groups of multiple emission bands. The less intense bands in
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the 400 nm to 460 nm range are due to relaxation to the ground state from the 5D3 excited
state. Whereas the more intense emission of the larger wavelengths is due to relaxation
from the 5D4 excited state (Figure 5.7). It is known that the emission color of Tb3+ dopant
is dependent on the concentration, therefore the concentration was held at 2 mol% where
green emission was observed.23,24

Figure 5.7 Energy – level diagram of Tb3+ showing the major emission bands.
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5.3.3 Radioluminescence
Radioluminescence is the deciding physical characteristic of the nanoparticles on
their potential as light sources for optogenetics. The emission spectra from the
2 % Tb:Y2O2S nanoparticles under X-ray excitation was consistent with the emission
profile for Tb3+ under UV excitation. The four main emission bands at 490 nm, 545 nm,
585 nm, and 620 nm are present under X-ray excitation albeit with some difference in
relative intensity. The band at 490 nm is much less intense relative to the main green
emission band at 545 nm. The same bright green color is observed from the nanoparticles
under X-ray excitation. Initially, formation of Tb:Y2O2S nanoparticles through the solidgas reaction led to necking of the particles. As discussed earlier in order to increase
dispersity less sulfur was used in the reaction which lead to a mixed phase product of
Tb:Y2O3/Y2O2S nanoparticles. The Tb:Y2O3/Y2O2S formed as uniform dispersible spheres
and had relatively low remaining Y2O3 and therefore their radioluminescence was tested.
The mixed phase nanoparticles exhibited characteristic Tb3+ emission under X-ray
excitation. The intensity of the radioluminescence for the mixed Tb:Y2O3/Y2O2S was
relatively low probably due to some quenching mechanism and it was believed that a
Y2O2S phase pure sample would produce increased intensity. This led to the investigation
of various other synthetic methods as described above, with the thiourea sulfidation
working the best by far. Once dispersible, phase pure Tb:Y2O2S nanoparticles were
achieved through the co-precipitation method their radioluminescence was tested. Indeed
it was found that the intensity of the phase pure sample is roughly 5X that compared to the
mixed phase sample (Figure 5.8).
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Figure 5.8 a) PXRD comparison of 2 % Tb:Y2O2S nanoparticles synthesized through
sulfidation. b) Radioluminescence (RL) emission spectra of 2 % Tb:Y2O2S and 2 %
Tb:Y2O2S/Y2O3 nanoparticles under X-ray excitation. c) SEM image of 2 % Tb:Y2O3
precursor nanoparticles before sulfidation. d) SEM image of 2 % Tb:Y2O2S/Y2O3
nanoparticles after sulfidation at 900 °C for 3 h.
The radioluminescence of phase pure Tb:Y2O2S nanoparticles was also compared
to the precursor Tb:Y2O3 and a commercial Ce:LSO standard (Figure 5.9). The emission
of the Tb:Y2O3 was hardly visible when compared to the Tb:Y2O2S particles. So the
oxysulfide phase now allows for strong green emission not previously available from the
rare earth oxide (RE2O3) nano-scintillators. Radioluminescence from the commercial
cerium doped LSO and nano terbium doped Y2O2S exhibit different emission profiles due
to their different dopant ions. The peaks of the Tb:Y2O2S nanoparticles are much more
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intense than the broad emission of the Ce:LSO standard. More impressive is the integrated
intensity of the Tb:Y2O2S nanoparticles was 2.5X the integrated intensity of the
commercial standard. The morphology, crystallinity, and crystallite dimensions and size
have a direct effect on radioluminescence efficiency.25–28 The Ce:LSO commercial powder
is made of micron size particles whereas the Tb:Y2O2S are particles under 100 nm,
spherical, and uniform (Figure 5.9). The comparative intensity is therefore particularly
impressive due to the difference in the crystallites size of the nanoparticles to the standard.

Figure 5.9 Radioluminescence (RL) emission spectra under X-ray excitation of
a) 2 % Tb:Y2O3 compared to 2 % Tb:Y2O2S nanoparticles and b) 2 % Tb:Y2O2S
nanoparticles compared to commercial standard cerium doped lutetium orthosilicate (LSO)
powder. SEM image of c) Ce:LSO commercial standard and d) Tb:Y2O2S nanoparticles.
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5.4 Summary and Conclusions
Tb:Y2O2S was identified as a potential target scintillator to be used for the
activation of green absorbing opsins in the field of optogenetics. For this role the nanoscintillators must be under 100 nm with uniform morphology. Three different synthetic
methods were evaluated for the production of Tb:Y2O2S nano-scintillators. First, a solidgas reaction for the sulfidation of Y2O3 nanoparticles to Y2O2S produced the desired phase
with aggregated morphology. Next, NaCO3 was introduced to provide a flux in effort to
produce a dispersible Y2O2S phase. The flux drastically changed the morphology to large
hexagonal plates. Finally, a co-precipitation method afforded phase pure and dispersible
Tb:Y2O2S nanoparticles. The nanoparticles exhibited the characteristic Tb3+ emission
profile under both UV and X-ray excitation. Radioluminescence of the Tb:Y2O2S proved
to be more intense than Tb:Y2O3 and mixed Tb:Y2O3/Y2O2S nanoparticles. Additionally,
the synthesized Tb:Y2O2S nanoparticles had a radioluminescence integrated intensity 2.5X
brighter than the Ce:LSO standard. The bright green emitting Tb:Y2O2S nano-scintillators
are promising light sources for future optogenetics studies.
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CHAPTER SIX
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE
STUDIES
6.1 Summary
Nano-scintillators were targeted as potential light sources for optogenetics that
could replace the need for surgical implantation of LEDs. The nano-scintillators needed to
be under 100 nm to get across the blood brain barrier, uniform and dispersible to enable
dosage calculations, and provide efficient scintillation. Achieving bright X-ray
luminescence in highly stable host materials at nanoparticle dimensions presents a series
of demanding synthetic challenges for new nanoparticles. In this work a series of
crystalline hosts and phases were optimized to produce high light yield under X-ray
excitation for three different luminescent ions (Ce3+, Eu3+ and Tb3+) all while maintaining
the required morphology. Exploration of a noninvasive light source for optogenetics led to
the production of numerous refractory materials as homogeneous and dispersible
nanoparticles.
In the case of Ce3+ emission, a modified core-shell synthetic route was employed
to produce rare earth containing silicate nanoparticles. In this method silica nanoparticles
were used as cores in order to provide a morphology template as well as the silicon needed
for the final orthosilicate phase. The rare earth ion was precipitated onto the silica core and
annealed to form a crystalline rare earth oxide shell. Further annealing produced a solid
state reaction between the silica core and rare earth shell generating silicate phase products.
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Ce:YSO nanoparticles were readily producible as 80 nm dispersible spheres. The Ce:YSO
nanoparticles produced approximately 1/8 the emission intensity under X-ray excitation
compared to a standard commercial Ce:LSO powder. The Ce:YSO nanoparticles did not
show toxicity in contact with NHDF cells for up to 72 h under the highest tested
concentrations. Additionally, initial biodistribution and immune response studies were
conducted on the Ce:YSO nanoparticles. Ce:YSO injected into mice brains passively
diffused from the injection site, but remained within brain for the tested time period. Initial
immune response to the injection was observed, but returned to baseline by day 9 post
injection. The Ce:YSO nanoparticles are promising nano-scintillators for optogenetics. In
order to continue to try to increase the radioluminescence targeting a heavier rare earth
such as gadolinium orthosilicate was attempted.
The core-shell approach was modified to try to introduce heavier host ions and
increase brightness. A series of Gd3+ containing hosts, Ce:Gd4.67(SiO4)3O, Ce:Gd2SiO5,
Ce:Gd2Si2O7, and mixed Ce:Gd/Lu nanophosphors were synthesized. The final phase of
the nanoparticles was carefully controlled through artful changes to the reaction chemistry
and dopant concentration to produce phase pure products. The mixed Ce:Gd/Lu
nanoparticles were also proven to be cleanly producible in the apatite, orthosilicate, or
pyrosilicate phase. Luminescence intensity was dependent on silicate phase, dopant
concentration, and gadolinium/lutetium ratio. The gadolinium- orthosilicate, pyrosilicate,
and all phases of the mixed gadolinium/lutetium displayed intense blue light emission
under UV excitation. Scintillation intensity was systematically increased by careful phase
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manipulation as well as lattice host optimization realized through adding lutetium into the
matrix.
Next, a simplified nano-scintillator target that could host europium to emit red light
under X-ray excitation was explored. Red emitting scintillators were targeted for newly
developed red absorbing opsins such as Chrimson.1 Europium doped rare earth oxide (RE
= Gd, Lu, Y) scintillators with nanosphere structure were synthesized through a urea
assisted precipitation with subsequent calcination. The reaction conditions were optimized
in order to produce the Eu:RE2O3 products as monodispersed, uniform, sub-100 nm
spheres. Of the Eu:RE2O3 nanoparticles, Eu:Gd2O3 yielded the most intense luminescence
under both UV and X-ray excitation. RL emission intensity increased with increased
annealing temperature and annealing time, but unfortunately, so did aggregation of the
Eu:RE2O3 particles. The 2 % Eu:Gd2O3 nanoparticles produced 2X greater integrated
intensity when compared to a Ce:LSO commercial standard. A thin undoped shell of Y2O3
was layered onto the nanoparticles to reduce surface quenching and increase RL intensity.
Additionally, a novel annealing protocol involving enclosing the nanoparticles in a
protective carbon coating increased RL emission intensity by 3X compared to the Eu:Y2O3
nanoparticles annealed at 800 °C for 2 h. The Eu:RE2O3 nanoparticles are particularly
exciting options for optogenetics and other biomedical applications, because they can be
readily made as uniform and monodisperse nanospheres as well as produce efficient
scintillation.
Tb:Y2O2S was identified as a potential target scintillator to be used for the
activation of green absorbing opsins in the field of optogenetics. Three different synthetic
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methods were assessed for the production of Tb:Y2O2S nano-scintillators. First, the
sulfidation of Y2O3 nanoparticles to Y2O2S was attempted through a solid-gas reaction that
yielded the desired phase with aggregated morphology. Second, a flux of NaCO3 was
introduced intending to produce a dispersible Y2O2S phase. Large hexagonal plates of
Y2O2S were produced through the flux method. Third, a co-precipitation method afforded
phase pure and dispersible Tb:Y2O2S nanoparticles. X-ray radioluminescence of the
Tb:Y2O2S proved to be more intense than Tb:Y2O3 and mixed Tb:Y2O3/Y2O2S
nanoparticles. Most impressively, the synthesized Tb:Y2O2S nanoparticles had a
radioluminescence integrated intensity 2.5X brighter than the Ce:LSO standard.
The work presented in the preceding chapters has led to the production of a number
of rare earth containing nano-scintillators. The nano-scintillators were designed to meet
strict requirements for a potential biomedical application, which resulted in dispersible and
uniform sub-100 nm spherical particles that are attractive candidates for optogenetics.
Future efforts should include surface modifications to enhance the particle’s targeting.
Additionally, the synthetic approaches and annealing protocols developed throughout this
work can be used to further create refractory species as dispersible sub-100 nm particles.

6.2 Recommendations for Future Work
6.2.1 Nano-Scintillators
Continued efforts could be made for radioluminescence (RL) intensity optimization
for the nano-scintillators presented throughout this work. For example, Ca2+ co-doping
within cerium doped rare earth orthosilicates has been shown to increase RL efficiency in
bulk materials.2,3 Thermoluminescence data suggests that the addition of Ca2+ reduces
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charge carrier traps that impede energy passage to the luminescent centers.4,5 Therefore,
co-doping and optimization of the dopant is an avenue to be explored with the nanosilicates. The carbon coating technology is only in its infancy and may be used for many
of the rare earth oxide hosts (e.g. LSO) that normally require annealing temperatures that
would otherwise lead to aggregation. The RE2O3 nanoparticles may exhibit even brighter
RL when higher annealing temperatures are used in combination with the carbon coating
technique. The rare earth oxysulfide RL intensity could also potentially be increased by
using denser rare earth metals such as gadolinium and lutetium. The incorporation of
denser elements has been credited for increased stopping power and therefore more
efficient scintillation.6
Moving forward the synthetic strategies and annealing techniques developed and
successfully demonstrated throughout this research project could enable further discovery.
For instance, the rich phase chemistry of the aluminum-yttrium oxide system is an
attractive target due to the multitude of phases in this family that contain interesting
physical properties. Yttrium aluminum garnet (Y3Al5O12, YAG) is popularly known and
used as a laser gain material, but YAG also exhibits radioluminescence when doped with
cerium.7–9 Yttrium aluminum perovskite (YAlO3,YAP) has been reported to host nearly
any rare earth dopant providing a number of attractive optical properties including bright
scintillation.10–12 The Y2O3 nanoparticles that have been shown to be readily producible
could be utilized as cores for the synthesis of yttrium-aluminum nanoparticles. Then an
aluminum oxide (Al2O3) precursor would be deposited as a shell on the Y2O3 and annealing
would induce a solid state reaction to produce the desired phases (Figure 6.1). Aluminum
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sulfate and aluminum phosphate salts are possible starting materials to precipitate
aluminum onto the Y2O3 cores. If these starting materials cannot produce a uniform
coating, aluminum isopropoxide should be tested as it has similarities to tetraethoxysilane
(TEOS), which is commonly employed for silica coating nanoparticles. Additionally, if the
temperature required to produce these proposed nanoparticle phases causes sintering of the
particles the carbon coating technique should be used to prevent the particles from
interacting with one another. It would be interesting to test the feasibility of phase control
at the nano-level in this system as was achieved in the gadolinium silicate family.

Figure 6.1 Schematic of proposed refractory nanoparticle core-shell synthesis.
More complex scintillating materials could also be targeted such as, Cs3RESi4O10F2
a group of scintillators reported as single crystals. The terbium analog has been described
as exhibiting brighter scintillation than Ce:LSO.13 The production of Cs3RESi4O10F2 could
be tackled by use of the core-shell method through two different routes. One route would
be to start with silica nanoparticles then to deposit CsF onto the particles followed by
coating on Tb2O3 starting materials. This coating could be achieved through urea assisted
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precipitation as was used to layer the RE2O3 shells on the silica cores to produce the rare
earth silicate nanoparticles. A potentially more simplified method would be to start with
CsREF4 nanoparticles and then coat on a layer of SiO2. The second method provides all
the elements necessary with only one shell coating. CsREF4 nanoparticles were readily
producible through modifications to the citrate method popular for producing upconverting
NaYF4 nanoparticles (Figure 6.2).14,15 As a specific example, CsTbF4 was synthesize by
3.62 mL of 0.221 M Tb(NO3)3 mixed with 7.14 mL of 0.224 M Na3C6H5O7 under vigorous
stirring. 16 mL of 1 M CsF was added to the solution and stirred for 1 h. The nanoparticles
were recovered by centrifugation and washed several times before being dried in an over
at 85 °C. However, it is recommended that further studies be done to optimize properties
such as size and rare earth metal. The materials described above are just a few examples
specific to scintillators, but it is believed these synthetic techniques could be taken
advantage of to produce an endless number of refractory materials as uniform, sub-100 nm
particles.
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Figure 6.2 SEM image of a) CsTbF4, b) CsHoF4, c) CsErF4, and d) CsNdF4 nanoparticles.
6.2.2 Surface Modification
Ideally, for noninvasive optogenetics the nano-scintillators would be injected
intravenously and targeted to the opsins. The synthesized nano-scintillator particles require
surface modification to enable targeting of the particles to the neurons of interest. One
possible targeting approach would be to utilize SNAP-tag technology which is an enzyme
based self-labeling protein. SNAP-tag is an appealing option as it is commercially available
in many expression vectors and can be expressed in opsins.16 The SNAP-tag protein is a
mutant of the O6-methylguanine-DNA methyltransferase protein which is responsible for
restoring the alkylated, mutagenic DNA lesion O6-methylguanine back to guanine.17 The
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SNAP-tag protein has been engineered to accept benzylguanine derivatives, which
provides a facile method for the irreversible attachment of a probe to a protein of interest
(Figure 6.3).18,19 This methodology could be implemented for the specific covalent
attachment of scintillating nanoparticles to opsins within neurons.

Figure 6.3 SNAP-tag labeling of benzylguanine derivatives.
In order to employ SNAP-tag labeling, the scintillating nanoparticles will require
benzylguanine functionality. “Click” chemistry could be implemented to facilitate this
surface modification. Click chemistry is a class of reactions that mimic nature’s ability to
effortlessly join small molecules without producing harmful byproducts.20,21 Click
reactions are typically simple, one pot reactions that are not disturbed by water and remain
stable in biological conditions, making them uniquely suited for optogenetic
applications.22,23 The copper(I) catalyzed variant of the Huisgen 1,3-dipolar cycloaddition
between azides and terminal alkynes would be suitable for functionalizing the
nanoparticles.24
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Figure 6.4 Proposed method for addition of azide functionality to scintillating cores.

Figure 6.5 Proposed synthesis of O6-[4-[2-propynylmethoxy]benzyl]guanine (PYBG). 25
The targeting functionalization would be conducted in a number of steps. First,
azide modifying the scintillating nanoparticles through the hydrolysis and subsequent
condensation of 3-azidepropyltrimethoxysilane onto the particles (Figure 6.4). This first
step has been carried out on the Ce:YSO nano-scintillators and the method is discussed in
Chapter 2. The second step would be to introduce a terminal alkyne group to O6benzylguanine. Typical syntheses of benzylguanine derivatives involve the nucleophilic
reaction

of

two

intermediate

compounds,
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1-(2-amino-7H-purin-6-yl)-1-methyl-

pyrrolidinium chloride and a para substituted benzyl alcohol.25,26 The synthesis of O6-[4[2-propynylmethoxy]benzyl]guanine (PYBG) has been previously reported by Song et al
(Figure 6.5). 4-[2-propynylmethoxy]benzyl alcohol can be synthesized by the substitution
reaction of propargyl bromide and 1-methylpyrrolidine and used as the benzyl alcohol
intermediate. A click transformation can then be carried out between O6-[4-[2propynylmethoxy]benzyl]guanine (PYBG) and the azide modified scintillating
nanoparticles joining them through the formation of a trizaole (Figure 6.6). Click
chemistry may be utilized to add other functionalities to the nanoparticles as well for
example fluorescent dye molecules can be attached to the particles surface in order to shift
light emission to an optimized wavelength for specific opsin activation or to enable image
analysis via fluorescence microscopy.

Figure 6.6 Functionalization of scintillating nanoparticles with benzylguanine targeting
ligand.
Once the nanoparticles have been modified with benzylguanine, the SNAP-tag can
then be used to covalently bind the nanoparticles to the opsins. If the use of cytotoxic
transition metals, such as the copper used to catalyze the click reaction, in the
functionalization of the nano-scintillators becomes a concern recent literature suggests a
rich future for copper free click chemistry. The use of highly strained alkynes, such as
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cyclooctynes,27 oxanorbornadiene,28 and dibenzocyclooctyne,29 have been reported to
react selectively with azides. If significant problems arise trying to use the SNAP-tag to
bind the nanoparticles other methods could be implemented. One alternative method would
be to use the strong interaction between biotin and the protein streptavidin. In this case,
traptavidin, a mutant of streptavidin, would be fused to a given opsin and biotin modified
nanoparticles could be produced through click chemistry.30
6.2.3 Biological Testing
Initial cytotoxicity studies using MTS assays were carried out on the various nanoscintillators to obtain preliminary biocompatibility assessments. The human cells exposed
to the nano-scintillators did not show a statistically significant difference in cell viability
compared to the control. It is recommended that further toxicity studies should be carried
out on the nanoparticles. Additional, cell lines such as liver cells should be tested due to
the liver’s role in nanoparticle clearance.31 The next step would be to run neural toxicity
studies followed by neural function in the presence of nanoparticles testing.
It will be important to gain information on how the nanoparticles travel through the
body such as retention time and locations of deposits. Preliminary distribution studies were
conducted on the Ce:YSO nanoparticles by collaborators at the University of New Mexico.
In their studies the particles were injected directly into the brain tissue. Future studies
should include systemic biodistribution.
Finally,

the

nano-scintillators

should

undergo

optogenetic

testing.

Electrophysiology studies can be used to determine if the scintillating nanoparticles are
able to active opsin proteins in neurons. Initial in vitro tests would likely involve rat brain
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slices exposed to the scintillating nanoparticles and be followed by in vivo tests in which
the particles would be injected into live rats. The scintillating nanoparticle design and
functionality will continue to be refined and tailored based on feedback from opsin design
and biological and optogenetic testing (Figure 6.7).

Figure 6.7 Schematic of nano-scintillators for optogenetics project feedback loop.
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